ILD, hospital admissions 1, main diag only

ILD_HOSPITAL_MAIN

interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Main diagnosis only: side diagnoses are not checked. Registry filters: Hospital discharge: ICD-10 — J84 Hospital discharge: ICD-9 — 515\|516 Hospital discharge: ICD-8 — 48499\|51701 1 out of 7 registries used, show all original rules.	5097
4. Check minimum number of events None	5097
5. Include endpoints None	5097
6. Filter based on genotype QC (FinnGen only)	5097

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J80-J84
Name in latin: Alii morbi interstitiales pulmonum

NAME	ILD_HOSPITAL_MAIN
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY	YES
HD_ICD_10_ATC
HD_ICD_10	J84
HD_ICD_9	515\|516
HD_ICD_8	48499\|51701
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to ILD, hospital admissions 1, main diag only based on the number of shared cases.

Similar with more cases:

Similar with less cases:

ILD medications: nintedanib

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5097	2088	3009
Unadjusted period prevalence (%)	1.07	0.71	1.33
Median age at first event (years)	69.04	66.56	70.75

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4525: Matched controls
45250

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UGC12

NOMESCO Finland

Flexible bronchoscopy

11.8

323.0

1651

2100

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

26.0

323.0

1600

931

TGC00

NOMESCO Finland

Bronchial lavation

35.0

323.0

1069

396

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

1030.3

323.0

1321

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

605.0

323.0

2206

XG410

NOMESCO Finland

Flow-volume spirometry

10.0

323.0

718

834

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

21.6

323.0

894

509

356

Kela drug reimbursment

Nintedanib and pirfenidone

4113.9

323.0

388

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

8.5

323.0

1667

2896

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.3

323.0

2253

8526

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

889.7

323.0

2461

284

Kela drug reimbursment

Nintedanib and pirfenidone

5055.9

323.0

466

H02AB06

ATC

prednisolone; systemic

5.4

323.0

3369

15769

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.8

323.0

3029

15792

L04AX05

ATC

pirfenidone; oral

+∞

321.7

305

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.9

282.9

1066

2679

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

7.0

282.8

761

1267

R06.0

ICD-10 Finland

Dyspnoea

3.3

265.9

1842

7815

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

10.7

255.0

518

539

L04AX01

ATC

azathioprine; systemic

8.6

237.2

549

717

R03AC02

ATC

salbutamol; inhalant

2.6

207.8

2690

16159

GD1AD

NOMESCO Finland

Thorax CT examination

6.7

206.7

569

955

L01XE31

ATC

[U] nintedanib; oral

+∞

205.8

196

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.7

201.0

2054

10689

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

86.9

199.4

223

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

35.8

194.9

254

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.0

176.5

617

1374

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.3

173.3

723

1926

J96.1

ICD-10 Finland

Chronic respiratory failure

8.8

170.8

384

470

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

52.0

169.0

204

L04AA06

ATC

mycophenolic acid; systemic

13.9

166.4

295

226

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

5.0

166.1

583

1299

J01MA14

ATC

moxifloxacin; systemic

3.7

149.1

724

2188

A02BC02

ATC

pantoprazole; systemic

2.3

140.8

3205

23275

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.4

140.8

779

2604

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

360.7

140.6

141

L01EX09

ATC

nintedanib; oral

+∞

136.1

130

48499

ICD-8 Finland

Acute interstitial pneumonia

+∞

131.9

126

P01BA02

ATC

hydroxychloroquine; oral

3.7

123.3

599

1792

R05

ICD-10 Finland

Cough

2.5

115.8

1111

5213

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.3

114.3

466

1189

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.1

109.0

464

1230

Z94.2

ICD-10 Finland

Lung transplant status

129.9

106.5

114

M05BA04

ATC

alendronic acid; oral

3.1

105.1

638

2246

R03BB04

ATC

tiotropium bromide; inhalant

2.8

104.4

788

3200

GDG10

NOMESCO Finland

Bilateral transplantation of lung

272.0

104.3

106

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.8

99.2

355

792

C03CA01

ATC

furosemide; systemic

2.0

98.4

1866

11757

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

97.3

1026

4991

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

92.3

990

4839

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

5.9

86.6

256

458

R4110

NOMESCO Finland

Physiotherapy

2.0

84.5

1378

8056

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.8

81.3

169

178

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

211.3

80.5

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

79.3

1077

5812

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

160.7

75.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

74.6

1227

7128

J01MA12

ATC

levofloxacin; systemic

2.1

74.4

1089

6040

J47

ICD-10 Finland

Bronchiectasis

6.5

74.0

201

322

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

69.3

592

2533

R03BA08

ATC

ciclesonide; inhalant

2.9

67.3

439

1598

J01AA02

ATC

doxycycline; systemic

1.8

66.7

3454

28850

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.3

65.9

258

626

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

64.6

1098

6399

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.6

64.6

505

2053

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.0

63.8

407

1458

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.0

63.1

393

1385

A07EC01

ATC

sulfasalazine; oral, rectal

2.7

62.6

467

1845

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

7.8

62.2

148

196

R02

ICPC

Shortness of breath/dyspnoea

2.2

61.7

685

3336

R04.2

ICD-10 Finland

Haemoptysis

3.8

61.7

279

771

XG466

NOMESCO Finland

Sleep oxymetry

4.1

61.3

255

654

WX892

NOMESCO Finland

Monitored bed care

2.6

60.7

487

2004

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

59.7

2064

15038

J01FA06

ATC

roxithromycin; oral

1.7

58.9

1772

12382

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

58.8

872

4799

XX4BW

NOMESCO Finland

46.6

56.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

56.2

1453

9667

127

Kela drug reimbursment

Transplant complication

7.4

56.1

137

189

L04AA13

ATC

leflunomide; oral

4.7

55.9

198

434

R50.9

ICD-10 Finland

Fever, unspecified

2.1

55.4

727

3797

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

9.0

55.0

119

135

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

54.9

679

3456

L04AD01

ATC

ciclosporin; systemic

6.1

54.8

155

262

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.5

53.7

262

770

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

53.3

1028

6203

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

52.7

889

5110

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

52.3

1248

8061

J43.9

ICD-10 Finland

Emphysema, unspecified

5.2

52.0

167

329

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

51.8

839

4746

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.5

51.7

429

1792

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.2

51.4

118

148

H02AB07

ATC

prednisone; oral

2.0

51.2

740

4007

WW200

NOMESCO Finland

Immunization

4.3

50.9

199

482

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

5.3

50.3

160

312

J01CA04

ATC

amoxicillin; systemic

1.7

49.8

3296

27957

R03AK08

ATC

formoterol and beclometasone; inhalant

3.8

49.4

223

614

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

18.8

49.2

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.5

49.0

151

284

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.7

47.4

352

1379

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

47.3

713

3912

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.0

46.9

287

996

R99

ICPC

Respiratory disease other

5.3

46.8

147

283

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

11.6

46.8

R05

ICPC

Cough

1.8

45.9

965

5950

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

45.7

384

1613

ZX108

NOMESCO Finland

Inhalation

9.5

45.4

102

GX1K5

NOMESCO Finland

Diffusion capacity

30.4

44.9

ZX120

NOMESCO Finland

Intravenous

2.2

43.9

497

2419

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

5.0

43.7

144

293

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

8.0

43.1

100

128

R81

ICPC

Pneumonia

3.4

42.0

218

672

R28

ICPC

Limited function/disability (R)

5.6

41.7

125

228

J84

ICD-10 Finland

Other interstitial pulmonary diseases

411.2

41.2

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.5

40.3

196

575

N02AX02

ATC

tramadol; systemic, rectal

1.5

40.0

1892

14412

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

39.7

769

4589

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

14.1

39.6

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

39.5

1369

9662

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.8

39.1

171

459

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

37.7

854

5343

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.3

36.8

196

616

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

36.6

628

3586

XG474

NOMESCO Finland

Exhalation nntrogen oxide

4.0

36.5

151

386

A02BC01

ATC

omeprazole; systemic

1.6

36.4

1296

9166

GX1D5

NOMESCO Finland

Flow volume spirometry

54.2

36.4

D86.0

ICD-10 Finland

Sarcoidosis of lung

6.1

35.7

164

WX721

NOMESCO Finland

Oxygen concentrator therapy

18.8

35.2

GDA10

NOMESCO Finland

Biopsy of lung

21.0

35.2

A07AA02

ATC

nystatin; oral

2.3

35.1

336

1505

R03BA01

ATC

beclometasone; inhalant

1.8

34.6

627

3645

C07AB07

ATC

bisoprolol; oral

1.5

34.5

2323

18879

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

30.3

33.8

A02BC05

ATC

esomeprazole; systemic

1.5

33.6

1686

12850

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

33.4

872

5667

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

8.6

32.3

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

32.2

1844

14414

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.9

32.1

137

361

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

32.0

532

2998

J01FA10

ATC

azithromycin; systemic

1.5

31.8

2013

16043

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

31.8

451

2395

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

31.8

581

3381

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

31.4

545

3113

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

31.4

1257

9077

M05BA07

ATC

risedronic acid; oral

2.9

31.3

194

679

L88

ICPC

Rheumatoid/seropositive arthritis

2.9

31.1

200

715

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

30.9

332

1568

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

70.4

30.9

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.9

30.8

129

334

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.3

30.7

116

273

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

30.2

495

2771

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.1

30.0

119

294

J94.1

ICD-10 Finland

Fibrothorax

68.4

29.9

R03BA02

ATC

budesonide; inhalant

1.7

29.7

706

4450

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

29.7

480

2673

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

16.9

29.7

XX9XE

NOMESCO Finland

Other ultrasound examination

7.0

29.6

107

M34.1

ICD-10 Finland

CR(E)ST syndrome

13.6

29.4

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

29.4

329

1582

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

26.9

29.2

E0000UV

ATC

1.5

29.2

1526

11638

WZC30

NOMESCO Finland

Teaching

1.8

28.5

593

3589

I50.0

ICD-10 Finland

Congestive heart failure

1.9

28.0

446

2468

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.3

27.9

146

454

L04AA01

ATC

[U] ciclosporin; systemic

4.5

27.7

101

230

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

42.8

27.7

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

27.5

347

1756

J92.9

ICD-10 Finland

Pleural plaque without asbestos

4.5

27.4

100

228

F1246

NOMESCO Finland

15.9

27.1

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

6.1

27.1

125

JN4BD

NOMESCO Finland

Extensive body CT

1.8

27.1

547

3274

R03BA05

ATC

fluticasone; inhalant

1.6

27.1

706

4560

J43.8

ICD-10 Finland

Other emphysema

12.8

27.0

XJC10

NOMESCO Finland

Oesophageal pH monitoring

8.6

26.7

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

22.5

26.5

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

26.3

329

1659

J01FF01

ATC

clindamycin; systemic

1.5

26.3

1090

7876

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.2

26.2

143

459

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

5.1

26.1

164

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

26.1

805

5427

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

8.0

25.8

G47.3

ICD-10 Finland

Sleep apnoea

1.6

25.6

848

5813

XG460

NOMESCO Finland

Short time oxymetry

3.5

25.2

120

348

D07AC01

ATC

betamethasone; topical

1.4

25.2

1396

10694

F2680

NOMESCO Finland

16.1

24.9

J01FA15

ATC

telithromycin; oral

1.9

24.8

369

1992

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

24.8

221

953

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

24.7

229

1008

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

24.6

789

5362

WX726

NOMESCO Finland

High-flow oxygen therapy

24.4

24.3

L01AA01

ATC

cyclophosphamide; systemic

8.1

24.1

N02BE01

ATC

paracetamol; systemic, rectal

1.5

23.6

3651

33447

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.0

23.6

324

1695

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

7.1

23.6

R03DC03

ATC

montelukast; oral

1.7

23.5

557

3492

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.0

23.1

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

23.0

458

2727

3A006

NOMESCO Finland

+∞

22.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

22.9

297

1519

M01CB01

ATC

sodium aurothiomalate; parenteral

3.8

22.9

266

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

8.0

22.6

A02BC03

ATC

lansoprazole; oral

1.4

22.4

1251

9545

J01FA09

ATC

clarithromycin; systemic

1.5

22.4

1102

8211

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

22.3

1478

11639

A01AB09

ATC

miconazole; local oral

1.8

22.3

382

2164

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.1

22.3

260

1273

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

22.2

1096

8164

R06AE07

ATC

cetirizine; oral

1.4

22.2

1507

11918

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

21.9

606

3958

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

13.2

21.9

5169X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy

+∞

21.9

J20

ICD-10 Finland

Acute bronchitis

1.8

21.8

383

2185

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

10.6

21.8

J01DB01

ATC

cefalexin; oral

1.4

21.7

3304

29842

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

21.3

1251

9623

Z57.2

ICD-10 Finland

Occupational exposure to dust

10.1

21.3

2AX04

NOMESCO Finland

23.2

21.2

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

21.2

583

3800

UJF32

NOMESCO Finland

Coloscopy

1.4

21.1

1128

8522

WX722

NOMESCO Finland

PEEP

2.1

21.0

239

1159

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.4

20.9

101

298

5163A

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis

+∞

20.8

WX872

NOMESCO Finland

Intensive care

2.0

20.7

257

1293

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

12.0

20.5

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.8

20.5

101

L04AB01

ATC

etanercept; parenteral

4.6

20.4

156

L04AB04

ATC

adalimumab; parenteral

4.2

20.3

184

N03AX16

ATC

pregabalin; oral

1.5

20.3

928

6791

AN1

Coronary angiography

1.6

20.2

635

4274

M04AA01

ATC

allopurinol; systemic

1.5

20.0

666

4546

J12.8

ICD-10 Finland

Other viral pneumonia

6.1

19.9

M34.0

ICD-10 Finland

Progressive systemic sclerosis

23.5

19.9

RS123

NOMESCO Finland

18.9

19.9

WX110

NOMESCO Finland

Local anesthesy

1.3

19.9

2532

22031

A03

ICPC

Fever

1.7

19.9

487

3076

H02AB04

ATC

methylprednisolone; systemic

1.6

19.9

596

3969

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

19.8

1171

8996

Z51.5

ICD-10 Finland

Palliative care

1.8

19.6

324

1812

5AB14

NOMESCO Finland

17.8

19.5

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

19.4

271

1427

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

19.4

661

4534

ZXA00

NOMESCO Finland

Right side

1.4

19.4

1174

9050

R06.2

ICD-10 Finland

Wheezing

2.3

19.4

188

847

J43.2

ICD-10 Finland

Centrilobular emphysema

9.6

19.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

19.2

357

2074

XG405

NOMESCO Finland

Education on PEF monitoring

3.7

19.2

234

SPAT1325

SPAT

Vaccination

1.4

19.0

1534

12406

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

18.9

1663

13631

J99.0

ICD-10 Finland

Rheumatoid lung disease

55.2

18.9

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.1

18.8

211

1016

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

5.2

18.7

113

GAA31

NOMESCO Finland

Thoracoscopy

8.3

18.6

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

18.6

1339

10618

J05AB11

ATC

valaciclovir; oral

1.6

18.5

483

3100

M81.4

ICD-10 Finland

Drug-induced osteoporosis

8.7

18.3

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

18.3

993

7488

WZA10

NOMESCO Finland

Long statement of health and health related matters

4.0

18.3

184

B01AA03

ATC

warfarin; systemic

1.4

18.2

1064

8130

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

18.0

151

632

L04AA24

ATC

abatacept; parenteral

10.7

17.9

J96.0

ICD-10 Finland

Acute respiratory failure

3.4

17.8

265

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.0

17.8

229

1167

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

3.2

17.7

293

R03AC03

ATC

terbutaline; inhalant

1.6

17.6

501

3285

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

95.4

17.6

XPX04

NOMESCO Finland

Angioscopy

10.1

17.4

SPAT1262

SPAT

Handing over of treatment supplies

1.4

17.3

806

5897

N02AA05

ATC

oxycodone; systemic

1.5

17.3

674

4755

1CX01

NOMESCO Finland

18.7

17.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

17.3

191

915

RK320

NOMESCO Finland

4.2

17.2

156

R01AD09

ATC

mometasone; nasal

1.3

17.1

1492

12164

R4190

NOMESCO Finland

Nutritional therapy

2.5

17.0

130

520

I73.0

ICD-10 Finland

Raynaud syndrome

4.0

16.9

173

C01DA14

ATC

isosorbide mononitrate; oral

1.4

16.9

845

6263

M35.1

ICD-10 Finland

Other overlap syndromes

7.8

16.8

WX002

NOMESCO Finland

Sedation and analgesia

1.4

16.7

822

6069

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

16.7

1068

8273

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

16.7

334

1987

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.7

16.7

115

433

R01AD12

ATC

fluticasone furoate; nasal

1.4

16.6

850

6325

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

16.5

425

2714

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.9

16.5

338

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

16.4

181

867

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

16.3

912

6893

M25.5

ICD-10 Finland

Pain in joint

1.4

16.2

948

7231

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.9

16.1

342

J80

ICD-10 Finland

Adult respiratory distress syndrome

6.7

16.0

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.4

16.0

130

M33.1

ICD-10 Finland

Other dermatomyositis

21.0

15.9

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.2

15.9

157

714

M33.2

ICD-10 Finland

Polymyositis

10.1

15.9

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

3.6

15.9

204

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

33.5

15.7

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

7.3

15.7

ZXA10

NOMESCO Finland

Bilateral

1.4

15.7

782

5787

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

15.6

285

1648

AK3

BLTX (both lung transplants)

+∞

15.6

J01MA02

ATC

ciprofloxacin; systemic

1.3

15.6

1636

13655

A28

ICPC

Limited function/disability NOS

1.4

15.6

723

5275

D07AC13

ATC

mometasone; topical

1.4

15.5

1082

8487

GX2C5

NOMESCO Finland

Short-lasting oximetry

13.8

15.5

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

4.1

15.4

144

C09AA05

ATC

ramipril; oral

1.3

15.4

1157

9180

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

15.3

216

1143

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

15.3

1041

8131

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.5

15.2

118

477

5BA08

NOMESCO Finland

5.3

15.2

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

15.2

125

522

J67.0

ICD-10 Finland

Farmer lung

13.1

15.1

GX2D5

NOMESCO Finland

Sleep oximetry

9.7

15.1

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.6

15.1

115

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

15.0

307

1839

318

Kela drug reimbursment

Teriparatide

6.3

15.0

N05CF01

ATC

zopiclone; oral

1.3

15.0

1334

10858

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

5.6

14.9

B02.9

ICD-10 Finland

Zoster without complication

1.8

14.9

247

1383

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

14.9

622

4444

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

15.1

14.8

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

14.8

433

2853

R29

ICPC

Respiratory symptom/complaint other

1.9

14.8

227

1237

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

56.8

14.8

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

14.8

248

1396

N02AA01

ATC

morphine; systemic, rectal

3.1

14.8

260

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

5.7

14.6

J18

ICD-10 Finland

Pneumonia, organism unspecified

4.4

14.6

119

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

14.6

313

1902

M05.1

ICD-10 Finland

Rheumatoid lung disease

80.3

14.6

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

14.6

348

M10.9

ICD-10 Finland

Gout, unspecified

1.7

14.5

319

1952

1XC02

NOMESCO Finland

4.7

14.5

102

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.2

14.3

J45.8

ICD-10 Finland

Mixed asthma

2.3

14.2

133

593

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.7

14.2

100

381

R03AK11

ATC

formoterol and fluticasone; inhalant

2.6

14.2

104

407

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.4

14.2

118

RK110

NOMESCO Finland

4.1

14.2

132

SPAT1263

SPAT

Sampling

1.3

14.1

1645

13873

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

14.1

269

1579

1240

FHL

Bronchoscopy

3.5

14.0

183

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.2

14.0

124

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

12.7

13.9

J01DA01

ATC

[U] cefalexin; systemic

1.3

13.8

2425

21530

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

13.8

561

3981

120

Kela drug reimbursment

Hypogammaglobulinaemia

20.1

13.8

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.4

13.7

202

XQ800

NOMESCO Finland

Prick test

1.9

13.7

211

1153

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.4

13.7

114

479

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

13.6

1097

8771

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

3.9

13.6

142

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

13.6

285

1718

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

13.6

247

1427

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

13.5

451

3064

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

13.5

179

928

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

140.4

13.4

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

13.4

434

2930

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.2

13.2

117

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.8

13.2

314

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.3

13.2

113

JN4AD

NOMESCO Finland

Body CT examination

1.6

13.1

329

2084

J46

ICD-10 Finland

Status asthmaticus

2.4

13.1

111

473

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.0

13.1

253

R4120

NOMESCO Finland

Occupational therapy

1.8

13.0

238

1377

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.5

13.0

100

404

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.8

12.9

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.3

12.9

196

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

12.9

314

1978

R03AC13

ATC

formoterol; inhalant

1.9

12.7

198

1087

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

12.6

300

1877

J02AC01

ATC

fluconazole; systemic

1.3

12.6

1177

9596

XF402

NOMESCO Finland

ECG with work load test

1.5

12.5

487

3419

TGD00

NOMESCO Finland

Needle biopsy of lung

5.3

12.5

M54.5

ICD-10 Finland

Low back pain

1.3

12.4

1086

8767

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

130.3

12.4

N03AX12

ATC

gabapentin; oral

1.4

12.4

555

4009

H05AA02

ATC

teriparatide; parenteral

5.8

12.3

R03BB01

ATC

ipratropium bromide; inhalant

1.8

12.3

199

1104

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.6

12.3

319

2038

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.4

12.3

172

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.8

12.2

213

1212

Angiography of the heart and coronary arteries

1.6

12.2

349

2285

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

10.5

12.2

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.2

12.2

119

543

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

12.2

347

2270

A01AB04

ATC

amphotericin B; local oral

1.8

12.1

196

1092

M05BX04

ATC

denosumab; parenteral

1.8

12.1

212

1212

ZXA05

NOMESCO Finland

Left side

1.3

12.1

1065

8606

WX740

NOMESCO Finland

Nitrogen oxide therapy

12.4

12.1

C03DA01

ATC

spironolactone; oral

1.5

12.1

476

3354

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.7

12.0

314

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

26.7

12.0

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

18.1

12.0

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

18.1

12.0

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

12.0

152

774

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

12.0

1229

10137

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

12.0

306

1950

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

3.5

11.9

155

M31.3

ICD-10 Finland

Wegener granulomatosis

6.0

11.9

M79.6

ICD-10 Finland

Pain in limb

1.3

11.9

1271

10539

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

5.5

11.9

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

11.9

278

1730

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

11.7

11.8

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

11.8

1211

9987

D07AB08

ATC

desonide; topical

1.5

11.7

370

2484

H02AB09

ATC

hydrocortisone; systemic

2.6

11.7

333

WX882

NOMESCO Finland

High dependency care

2.1

11.6

125

596

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

6.5

11.5

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

7.1

11.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

11.5

212

1234

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

120.3

11.4

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

11.4

242

1470

R03AC12

ATC

salmeterol; inhalant

1.8

11.4

198

1130

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

8.3

11.3

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

10.5

11.2

S18

ICPC

Laceration/cut

1.3

11.2

1668

14386

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

17.1

11.2

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.0

11.1

146

756

L01CB

ATC

Podophyllotoxin derivatives

7.6

11.1

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

11.1

137

692

R01AD08

ATC

fluticasone; nasal

1.3

11.1

900

7172

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

11.1

1145

9436

E000001

ATC

1.4

11.0

716

5516

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

11.0

1182

9794

RS230

NOMESCO Finland

5.7

10.8

R74

ICPC

Upper respiratory infection acute

1.4

10.8

704

5424

R2110

NOMESCO Finland

Giving the first information

1.7

10.8

214

1270

J93.8

ICD-10 Finland

Other pneumothorax

4.6

10.7

NDG30

NOMESCO Finland

Fusion of wrist, total

5.0

10.7

L04AC07

ATC

tocilizumab; parenteral

9.6

10.7

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

9.6

10.7

ZX197

NOMESCO Finland

17.8

10.7

293

Kela drug reimbursment

Baricitinib

17.8

10.7

L04AA37

ATC

baricitinib; oral

17.8

10.7

SPAT1255

SPAT

Intravenous administration of medicine

1.6

10.7

269

1707

B01AB05

ATC

enoxaparin; parenteral

1.3

10.6

1220

10181

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

10.6

221

1333

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

10.6

175

985

J98.4

ICD-10 Finland

Other disorders of lung

8.0

10.6

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

10.5

355

2421

H03AA01

ATC

levothyroxine sodium; systemic

1.3

10.5

790

6225

XX7LW

NOMESCO Finland

9.2

10.5

M05BA06

ATC

ibandronic acid; systemic

2.4

10.5

367

R24

ICPC

Haemoptysis

4.3

10.5

Z94.3

ICD-10 Finland

Heart and lungs transplant status

+∞

10.4

304

Kela drug reimbursment

Dornase alfa

+∞

10.4

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

+∞

10.4

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

10.4

140

734

3006

Kela drug reimbursment

Baricitinib

16.1

10.3

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

10.3

730

5699

Z31.5

ICD-10 Finland

Genetic counselling

2.1

10.2

117

574

J01GB01

ATC

tobramycin; inhalant, parenteral

23.4

10.2

XF404

NOMESCO Finland

Ambulatory ECG

1.5

10.2

377

2621

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.7

10.2

245

I27.0

ICD-10 Finland

Primary pulmonary hypertension

7.5

10.2

C10AA03

ATC

pravastatin; oral

1.5

10.1

330

2230

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

10.1

131

676

NG1DA

NOMESCO Finland

X-ray of knees

2.5

10.1

317

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.9

10.0

137

722

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

10.0

245

1548

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.7

10.0

242

B37.0

ICD-10 Finland

Candidal stomatitis

3.5

10.0

130

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

5.3

9.9

WX402

NOMESCO Finland

General anaesthesia

1.4

9.9

534

3984

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

9.9

453

XX4AW

NOMESCO Finland

16.7

9.9

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.8

9.8

106

J02AC03

ATC

voriconazole; systemic

8.1

9.8

132

Kela drug reimbursment

Sarcoidosis

3.8

9.8

107

TK800

NOMESCO Finland

Hemodialysis

2.2

9.7

429

J45

ICD-10 Finland

Asthma

1.5

9.7

309

2076

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.2

9.7

101

475

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

9.7

914

7428

H26.3

ICD-10 Finland

Drug-induced cataract

4.4

9.6

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.7

9.6

109

RK250

NOMESCO Finland

4.5

9.5

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.7

9.5

185

1095

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

9.5

1661

14507

A02BA03

ATC

famotidine; systemic

1.7

9.5

176

1025

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

9.5

1442

12406

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.9

9.4

197

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

9.4

320

2183

L03

ICPC

Low back symptom/complaint

1.3

9.4

792

6333

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

9.4

1293

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.2

9.4

153

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

9.4

390

2774

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

+∞

9.4

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

+∞

9.4

2770A

ICD-9 Finland

Other and unspecified disorders of metabolism, Cystic fibrosis

+∞

9.4

Z71.8

ICD-10 Finland

Other specified counselling

1.3

9.4

761

6055

SBA10

NOMESCO Finland

Measurement of excretion of saliva

3.4

9.4

132

J05AB01

ATC

aciclovir; systemic

1.3

9.3

690

5416

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

21.7

9.3

M01CB03

ATC

auranofin; oral

3.4

9.3

127

D02AE01

ATC

carbamide; topical

1.6

9.3

228

1440

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

9.3

514

3853

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

8.7

9.3

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.7

9.3

102

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.8

9.3

152

853

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

9.2

120

619

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

9.2

224

1412

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.7

9.2

224

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

4.6

9.2

4040

NOMESCO Finland

13.7

9.2

A02BA02

ATC

ranitidine; systemic

1.3

9.1

807

6491

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

4.0

9.1

R05FB02

ATC

cough suppressants and expectorants

1.2

9.0

1456

12588

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

36.7

9.0

D07XC01

ATC

betamethasone, combinations; topical

1.4

9.0

451

3321

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

3.9

9.0

WX204

NOMESCO Finland

Axillary plexus blockaced

2.0

9.0

105

522

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.1

8.9

148

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

8.9

2051

18385

J37.0

ICD-10 Finland

Chronic laryngitis

2.0

8.9

111

565

J01FA01

ATC

erythromycin; systemic

1.4

8.9

375

2680

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

3.8

8.8

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.3

8.8

349

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

8.7

115

600

R03BB05

ATC

aclidinium bromide; inhalant

5.9

8.7

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

8.7

310

2137

B01AC04

ATC

clopidogrel; oral

1.3

8.7

731

5839

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.7

8.7

208

R03BB07

ATC

umeclidinium bromide; inhalant

3.3

8.7

124

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

50.1

8.7

-1

NOMESCO Finland

1.3

8.6

986

8190

RS220

NOMESCO Finland

2.8

8.6

186

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

8.6

1012

8435

S97

ICPC

Chronic ulcer skin

1.6

8.6

227

1463

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

6.1

8.6

WX720

NOMESCO Finland

Own respiration

1.8

8.5

144

820

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.8

8.5

J01XB01

ATC

colistin; inhalant, parenteral

20.0

8.5

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.1

8.4

444

E000002

ATC

1.4

8.4

335

2365

WVA20

NOMESCO Finland

Medicine administration

2.1

8.4

419

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

4.1

8.4

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

8.4

137

771

A46

ICD-10 Finland

Erysipelas

1.3

8.3

562

4348

RS221

NOMESCO Finland

2.6

8.3

226

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

8.3

508

3873

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

10.7

8.3

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.2

8.3

341

A07EC02

ATC

mesalazine; oral, rectal

1.7

8.3

163

972

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

8.2

1179

10045

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.6

8.2

228

R03DA04

ATC

theophylline; systemic, rectal

1.6

8.2

232

1522

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

8.2

384

2797

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.2

8.1

358

L04AA17

ATC

[U] adalimumab; parenteral

5.7

8.1

M06

ICD-10 Finland

Other rheumatoid arthritis

3.8

8.1

C08CA02

ATC

felodipine; oral

1.4

8.1

409

3018

L04AB05

ATC

certolizumab pegol; parenteral

8.1

C02KX01

ATC

bosentan; oral

17.2

8.1

B59

ICD-10 Finland

Pneumocystosis

11.7

8.1

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

4.8

8.0

ZX114

NOMESCO Finland

Intramuscular

2.5

8.0

244

M48.0

ICD-10 Finland

Spinal stenosis

1.3

8.0

496

3787

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

8.0

457

L04AB06

ATC

golimumab; parenteral

4.6

8.0

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

5.5

8.0

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

8.0

160

960

R03AC19

ATC

olodaterol; inhalant

4.1

7.9

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

7.9

424

3161

NDL52

NOMESCO Finland

Tenosynovectomy of hand

3.6

7.9

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

7.9

173

1060

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.4

7.9

107

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

7.9

308

2168

291

Kela drug reimbursment

Tofacitinib

6.6

7.9

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

13.0

7.9

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.5

7.8

256

1734

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

7.8

725

5860

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

7.8

384

2821

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.7

7.8

185

R13

ICD-10 Finland

Dysphagia

1.5

7.8

242

1622

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

7.8

604

4767

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.5

7.7

228

SPAT1260

SPAT

Consultation of another employee

1.3

7.7

646

5151

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

45.0

7.7

51709

ICD-8 Finland

Other chronic interstitial pneumonia, Unspecified

15.0

7.7

C08CA05

ATC

nifedipine; systemic

1.5

7.7

283

1966

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

7.7

822

6766

A04

ICPC

Weakness/tiredness general

1.4

7.7

456

3459

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

5.9

7.7

L01BB01

ATC

7.4

7.7

R04.0

ICD-10 Finland

Epistaxis

1.5

7.6

298

2094

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

7.6

193

1233

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.6

1301

11275

A02BA04

ATC

nizatidine; systemic

1.4

7.6

317

2259

FXE00

NOMESCO Finland

Use of ECLA

18.4

7.6

DHA10

NOMESCO Finland

Biopsy of cavity of nose

3.4

7.6

100

C02KX04

ATC

macitentan; oral

11.8

7.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

7.5

144

851

J94.8

ICD-10 Finland

Other specified pleural conditions

2.1

7.5

357

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

3.9

7.5

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

10.0

7.5

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

7.5

442

3345

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

7.5

147

874

R63.4

ICD-10 Finland

Abnormal weight loss

1.7

7.5

133

770

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

3.4

7.5

101

R04

ICPC

Breathing problem other

1.8

7.5

116

642

ZX100

NOMESCO Finland

Oral

2.3

7.4

268

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

5.0

7.4

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

7.4

130

749

3AC01

NOMESCO Finland

2.8

7.4

164

XJC00

NOMESCO Finland

Oesophageal manometry

4.5

7.4

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.6

7.3

188

L57.0

ICD-10 Finland

Actinic keratosis

1.4

7.3

420

3167

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.0

7.3

468

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

7.3

278

1947

UGC08

NOMESCO Finland

Rigid bronchoscopy with biopsy of lung

+∞

7.3

5168X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies

+∞

7.3

M01AH02

ATC

rofecoxib; oral

1.3

7.2

496

3845

N07BA03

ATC

varenicline; oral

1.8

7.2

120

682

M32

ICD-10 Finland

Systemic lupus erythematosus

15.8

7.2

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

15.8

7.2

I50.1

ICD-10 Finland

Left ventricular failure

1.5

7.2

213

1412

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

7.2

282

1988

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

7.1

426

3231

E000003

ATC

1.7

7.1

144

868

R53

ICD-10 Finland

Malaise and fatigue

1.3

7.1

733

6001

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

20.0

7.1

N06DA02

ATC

donepezil; oral

0.6

7.1

104

1717

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

7.1

407

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

7.1

332

2421

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.4

7.1

223

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

12.0

7.1

M02AA07

ATC

piroxicam; topical

1.2

7.1

1395

12245

M10

ICD-10 Finland

Gout

1.6

7.1

179

1146

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

5.6

7.0

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

8.8

7.0

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

7.0

1518

13434

A91

ICPC

Abnormal result investigation NOS

1.6

7.0

153

942

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

7.0

118

673

K76.9

ICD-10 Finland

Liver disease, unspecified

2.5

7.0

199

C10AA01

ATC

simvastatin; oral

1.2

7.0

2010

18237

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

7.0

1791

16088

XX1VW

NOMESCO Finland

Written report from radiologist

3.3

7.0

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.0

7.0

389

ED1AA

NOMESCO Finland

Mandipular X-ray examination

3.5

7.0

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

6.3

6.9

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

6.9

111

622

602

Kela drug reimbursment

Children's severe malnutrition

13.8

6.9

XA421

NOMESCO Finland

Nocturnal polygraphy

4.6

6.9

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.6

6.9

187

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

4.0

6.9

207

Kela drug reimbursment

Chronic arrhythmias

1.3

6.9

654

5302

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

8.3

6.8

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.3

6.8

D07AD01

ATC

clobetasol; topical

1.3

6.8

511

4012

5823

FHL

Lung avobiopsy and wedge resection

9.3

6.8

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.4

6.8

235

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

5.3

6.8

B37.03

ICD-10 Finland

Chronic atrophic candida infection in the mouth

5.3

6.8

U02

ICPC

Urinary frequency/urgency

1.3

6.8

407

3094

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.5

6.7

230

1578

S29

ICPC

Skin symptom/complaint other

1.3

6.7

593

4756

R52.0

ICD-10 Finland

Acute pain

1.9

6.7

446

B01AF02

ATC

apixaban; oral

1.3

6.7

413

3150

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

6.7

1421

12537

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

6.7

222

1511

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.5

6.7

213

1436

-44

ICPC

Preventive immunization/medic

1.4

6.7

319

2332

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

3.6

6.7

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.6

795

6623

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

6.6

2315

21321

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

6.6

247

1726

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

6.6

150

932

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

6.6

1404

12389

T90

ICPC

Diabetes non-insulin dependent

1.2

6.6

928

7865

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

2.8

6.6

140

J43.1

ICD-10 Finland

Panlobular emphysema

12.2

6.6

Z50.1

ICD-10 Finland

Other physical therapy

1.5

6.6

195

1295

R06AE09

ATC

levocetirizine; oral

1.4

6.6

381

2881

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

4.0

6.6

D07AA02

ATC

hydrocortisone; topical

1.3

6.6

404

3081

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.4

6.6

256

1804

L95

ICPC

Osteoporosis

1.8

6.5

112

644

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

10.0

6.5

S22.2

ICD-10 Finland

Fracture of sternum

3.3

6.5

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

6.5

107

1716

L02

ICPC

Back symptom/complaint

1.5

6.5

244

1705

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.5

1768

15938

A01

ICPC

Pain general/multiple sites

1.4

6.5

251

1767

C10AA05

ATC

atorvastatin; oral

1.2

6.5

1626

14556

ZX121

NOMESCO Finland

Central venous catheter

4.5

6.4

TEA00

NOMESCO Finland

Biopsy of lip

2.9

6.4

128

N19

ICD-10 Finland

Unspecified kidney failure

1.6

6.4

145

901

51701

ICD-8 Finland

Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)

69.9

6.4

4038

NOMESCO Finland

69.9

6.4

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

6.4

565

4533

UDM02

NOMESCO Finland

Sinoscopy

2.0

6.4

351

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

6.4

269

1925

D72.1

ICD-10 Finland

Eosinophilia

4.0

6.4

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.2

6.4

275

WNF00

NOMESCO Finland

Infection source and contact determination

3.7

6.4

R06AX27

ATC

desloratadine; oral

1.3

6.3

689

5674

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.6

6.3

141

874

UGC02

NOMESCO Finland

Rigid bronchoscopy

4.9

6.3

S22.3

ICD-10 Finland

Fracture of rib

1.5

6.3

232

1616

C10AX09

ATC

ezetimibe; oral

1.3

6.3

408

3134

F03

ICD-10 Finland

Unspecified dementia

0.6

6.3

1238

M79.1

ICD-10 Finland

Myalgia

1.4

6.3

364

2746

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

6.3

400

3063

D02AX

ATC

Other emollients and protectives

1.8

6.3

510

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

5.5

6.3

N06AX11

ATC

mirtazapine; oral

1.2

6.3

1064

9186

TNG10

NOMESCO Finland

Puncture of knee

2.6

6.3

163

GDB01

NOMESCO Finland

Thoracoscopic resection of bullae of lung

18.0

6.3

D84.8

ICD-10 Finland

Other specified immunodeficiencies

+∞

6.2

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.0

6.2

403

N17.8

ICD-10 Finland

Other acute renal failure

2.4

6.2

200

XQ860

NOMESCO Finland

Laser Doppler measurement/scan of capillary perfusion

26.7

6.2

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.0

6.2

390

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.2

6.2

280

NDG74

NOMESCO Finland

Fusion of first IP joint

4.8

6.2

NXL00

NOMESCO Finland

Biopsy of muscle

4.8

6.2

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.2

874

7405

R60.0

ICD-10 Finland

Localized oedema

1.3

6.2

431

3346

N30.2

ICD-10 Finland

Other chronic cystitis

2.8

6.2

127

K51.8

ICD-10 Finland

Other ulcerative colitis

2.5

6.2

175

M54

ICD-10 Finland

Dorsalgia

1.4

6.2

316

2343

3A064

NOMESCO Finland

3.6

6.2

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

6.2

501

3979

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.8

6.2

GDB10

NOMESCO Finland

Wedge resection of lung

6.3

6.1

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.6

6.1

139

866

SBA00

NOMESCO Finland

Microbiological examinations

1.9

6.1

411

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.2

6.1

262

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.1

2402

22269

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.6

6.1

167

1089

L08

ICPC

Shoulder symptom/complaint

1.3

6.1

643

5275

XF622

NOMESCO Finland

Measurement of minute volume of heart

4.2

6.1

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

12.5

6.1

XG430

NOMESCO Finland

Spiroegometry

12.5

6.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

6.1

378

2888

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.1

6.1

302

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

8.6

6.0

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.2

6.0

248

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

10.0

6.0

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

6.0

268

1937

L28

ICPC

Limited function/disability (L)

1.3

6.0

628

5144

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(4010399)

1032

2929

4.16

323.31

2.0

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

896

2304

4.51

319.98

2.1

1.9

g/l

1.1

1.4

3.96

834

2062

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

727

1595

5.15

315.26

1.8

u/l

38.5

38.4

0.04

660

1363

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1812

5985

4.15

307.65

1.4

1.3

iu/ml

56.8

37.9

3.29

625

1820

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1146

1642

8.71

307.65

3.2

2.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

511

635

8.83

307.65

1.5

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1672

5619

3.94

307.65

1.3

1.2

u/ml

29.7

13.3

2.44

490

2045

(44806118)

403

437

9.93

307.65

2.7

1.3

—

(3022096) Basophils/100 leukocytes in Blood

3588

18808

4.07

307.65

12.6

5.8

0.6

0.7

3.23

3519

17372

(3019069) Monocytes/100 leukocytes in Blood

3624

19426

4.00

307.65

13.2

6.1

8.9

0.09

3549

17984

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

493

582

9.27

307.65

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1526

5444

3.57

307.65

2.7

1.8

—

(3023419) Bacteria identified in Sputum by Culture

557

569

10.87

307.65

2.7

2.4

—

(44790048)

403

437

9.93

307.65

2.7

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

727

1137

7.29

307.65

1.6

1.4

iu/ml

11.6

18.9

0.64

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

620

715

9.73

307.65

1.2

u/ml

45.6

0.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1905

7950

3.23

307.65

2.8

1.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

575

897

7.10

307.65

1.4

1.2

u/ml

43.6

44.3

0.02

(3013650) Neutrophils [#/volume] in Blood by Automated count

3924

23970

3.77

307.65

15.6

8.7

e9/l

4.7

4.3

27.86

3635

20737

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

553

831

7.34

307.65

1.4

1.2

titre

177.3

156.0

0.06

(3002030) Lymphocytes/100 leukocytes in Blood

3626

19780

3.89

307.65

12.9

6.0

24.6

26.4

18.57

3550

18177

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

780

1031

8.75

307.65

2.4

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1145

2913

4.78

307.65

4.0

2.7

g/l

10.4

10.5

0.39

1093

2641

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

521

596

9.62

307.65

2.4

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

908

1380

7.79

307.65

1.8

1.5

titre

283.6

242.0

0.19

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1229

1759

8.89

307.65

1.5

1.6

u/ml

19.2

19.0

0.01

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1520

5461

3.54

307.65

2.6

1.8

—

(3006315) Basophils [#/volume] in Blood

3835

20613

4.48

307.65

12.0

5.5

e9/l

0.0

4.21

3508

17520

(44790047)

403

437

9.93

307.65

2.7

1.3

—

(44790049)

403

437

9.93

307.65

2.7

1.3

—

(3013115) Eosinophils [#/volume] in Blood

3889

21262

4.50

307.65

12.7

5.7

e9/l

0.2

2.55

3595

18322

(3001604) Monocytes [#/volume] in Blood

3826

20489

4.48

307.65

12.0

5.5

e9/l

0.7

0.6

22.00

3494

17394

(3006504) Eosinophils/100 leukocytes in Blood

3618

19336

4.00

307.65

12.7

5.8

2.7

2.9

3.66

3543

17846

(3042631) Mycobacterium sp identified in Specimen

508

641

8.69

307.65

3.1

2.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

660

261

28.90

307.65

2.3

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

769

984

9.03

307.65

2.4

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

522

692

8.29

307.65

1.3

1.2

u/ml

19.3

2.5

1.63

(3000492) Spirometry study

1106

3246

4.07

307.65

2.9

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

404

154

28.41

307.65

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

620

570

12.25

307.65

2.1

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

726

700

11.93

307.65

2.1

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

561

830

7.47

307.65

1.4

1.2

u/ml

8.3

3.1

0.80

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

608

764

8.90

307.65

2.4

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

798

1262

7.31

307.65

1.3

1.2

u/ml

2.0

0.9

1.10

120

(3006184) Hemoglobin [Mass/volume] in Capillary blood

619

1089

6.33

307.65

2.3

2.2

g/l

129.3

127.3

0.59

234

817

(3037692) Legionella sp identified in Specimen by Organism specific culture

291

121

25.45

307.65

2.0

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

3840

20975

4.37

307.65

12.1

5.6

e9/l

1.9

0.13

3536

18100

(42870588) Differential panel, method unspecified - Blood

3088

14511

3.86

307.65

11.7

5.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

529

636

9.17

307.65

1.8

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

480

486

10.80

307.65

2.7

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

2045

4623

6.72

307.65

1.5

1.3

titre

596.6

516.7

1.01

617

979

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

564

841

7.42

307.65

1.4

1.2

u/ml

13.6

6.7

1.16

127

131

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

498

560

9.75

307.65

1.8

1.4

—

(3018010) Neutrophils/100 leukocytes in Blood

3591

19477

3.86

307.65

12.4

5.7

60.4

58.2

22.19

3517

17995

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

675

1026

7.43

307.65

2.0

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

509

744

7.49

307.65

12.8

4.5

iu/ml

1646.7

2568.9

0.15

121

103

(3019060) Gas panel - Arterial blood

1151

3304

4.21

307.65

4.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

949

998

11.46

307.65

1.9

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

569

1030

6.09

304.51

1.9

1.4

g/l

0.2

2.33

548

973

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

572

1069

5.90

295.84

1.9

1.5

g/l

1.2

1.46

553

1007

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1483

5658

3.29

294.46

9.0

6.8

kpa

5.0

5.1

0.71

1431

5369

(3027801) Oxygen [Partial pressure] in Arterial blood

1482

5657

3.28

293.96

9.0

6.8

kpa

10.2

12.1

50.14

1433

5366

(3003396) Base excess in Arterial blood by calculation

1466

5644

3.24

285.63

9.1

6.8

mmol/l

1.4

1.1

1.97

1227

4325

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

379

483

8.40

280.52

3.4

3.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

770

1994

4.37

270.18

1.6

1.3

u/ml

255.8

218.6

0.52

719

1815

(3000494) Fungus identified in Specimen by Culture

1244

4754

3.14

240.77

2.4

1.4

—

(3023368) Bacteria identified in Blood by Culture

2458

13508

2.58

234.49

6.1

4.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

485

973

5.40

230.80

1.8

1.9

mg/l

10.8

12.7

2.05

457

890

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

139

40.80

229.59

3.1

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

1030

3658

3.28

224.23

6.0

3.9

0.8

0.9

0.70

358

1093

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

172

19.97

222.46

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

172

19.97

222.46

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

172

19.97

222.46

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

172

19.97

222.46

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3466

22870

2.61

217.53

10.2

6.2

umol/l

11.3

12.4

4.52

3371

21683

(3002179) Metamyelocytes/100 leukocytes in Blood

952

3308

3.31

214.09

5.8

3.8

0.6

0.7

0.66

277

775

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

294

9.27

211.10

2.0

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

294

394

7.86

207.82

1.3

1.2

u/ml

59.7

37.1

0.62

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

172

103

17.25

207.66

1.3

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

241

252

9.99

207.47

2.1

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

240

251

9.98

206.58

2.1

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

268

324

8.68

206.40

1.4

1.3

g/l

7.7

6.7

2.05

185

225

(3024139) IgG subclass 3 [Mass/volume] in Serum

267

324

8.64

205.00

1.4

1.3

g/l

0.5

0.4

1.85

185

228

(3028192) IgG subclass 2 [Mass/volume] in Serum

267

324

8.64

205.00

1.4

1.3

g/l

3.0

2.9

0.41

186

228

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

352

586

6.38

203.50

5.5

2.4

u/ml

749.9

2933.5

1.04

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

361

619

6.20

202.59

1.4

1.2

u/ml

62.2

39.8

1.41

(4062490)

267

329

8.51

202.45

1.4

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1084

4215

3.00

199.88

1.5

1.6

—

(3016502) Oxygen saturation in Arterial blood

1231

5135

2.84

199.37

9.9

7.1

93.8

95.4

12.85

1194

4928

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

787

2550

3.47

197.00

10.8

8.9

mmol/l

24.7

24.3

2.42

725

2353

(3024980) IgG subclass 4 [Mass/volume] in Serum

333

543

6.49

196.40

1.7

1.6

g/l

0.9

0.14

240

416

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3190

20823

2.42

195.46

9.6

6.2

mmol/l

1.2

4.80

3005

18703

(3018418) pH of Serum or Plasma

2360

13517

2.39

195.34

5.5

4.1

7.4

0.87

539

2524

(3025159) Blasts/100 leukocytes in Blood

904

3235

3.18

192.09

6.0

4.0

0.3

0.2

0.08

293

848

(3004616) Nuclear Ab [Presence] in Serum

292

428

7.18

190.46

1.3

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

942

3479

3.09

189.42

6.1

3.9

0.1

0.94

329

1022

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

271

372

7.64

187.43

2.1

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4109

30492

2.79

185.48

9.8

4.1

mm/h

18.3

13.9

47.16

4012

27838

(3021589) Normoblasts [#/volume] in Blood

2851

17982

2.33

185.21

19.0

10.1

e9/l

0.0

0.59

2443

14580

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2514

15082

2.32

183.30

4.2

3.2

ng/l

1769.6

1778.8

0.03

2285

13130

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

277

411

7.07

178.55

2.0

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1634

8243

2.45

176.27

9.1

4.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

282

439

6.74

173.72

2.0

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3340

22950

2.32

171.20

10.4

6.9

mmol/l

1.2

1.42

2818

19286

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

222

272

8.49

168.88

1.2

1.1

u/ml

32.3

3.1

1.39

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

226

290

8.11

165.45

1.3

1.1

u/ml

60.1

41.6

0.44

(3042936) Bacteria identified in Isolate by Culture

1350

6421

2.50

163.84

2.6

2.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

224

289

8.06

163.23

1.3

1.1

u/ml

72.6

73.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

367

777

5.01

163.09

4.6

3.6

59.7

58.3

1.07

367

777

(3038026) Centromere Ab [Units/volume] in Serum

227

299

7.90

162.53

1.3

1.1

u/ml

33.3

66.6

0.60

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

203

251

8.38

153.19

4.2

3.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1358

6693

2.40

150.66

1.9

1.5

g/l

2.9

2.6

2.54

983

3839

(3042733) HLA Ab [Presence] in Serum

127

15.48

145.47

4.2

4.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

151

136

11.41

143.93

2.1

1.9

u/ml

67858.4

26551.7

0.25

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

321

678

4.99

142.77

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

320

675

4.99

142.54

1.3

1.4

u/ml

33.2

14.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

295

589

5.25

139.98

1.4

u/ml

136.2

123.7

0.22

119

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2099

12718

2.11

137.62

5.5

3.2

u/l

33.7

37.5

1.06

2013

11989

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

612

2116

3.15

135.27

2.4

1.9

ug/l

2.0

2.4

0.21

559

1827

(3001964) Herpes simplex virus Ag [Presence] in Specimen

127

13.40

134.16

3.0

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1604

8843

2.19

133.61

2.5

1.7

mg/l

1.6

1.4

0.74

1336

6870

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4161

32922

2.44

131.86

14.8

7.7

u/l

78.2

80.7

2.72

4077

30807

(40758558) Short blood count panel - Blood

1819

10598

2.11

130.77

11.1

6.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1013

4670

2.46

127.98

11.3

7.4

g/l

124.1

120.3

6.58

981

4494

(3021879) Hepatitis B virus core Ab [Presence] in Serum

602

2160

3.03

124.33

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

709

2791

2.79

123.46

12.3

7.0

mmol/l

25.0

24.8

0.74

701

2767

(3024932) HLA-DR beta [Type]

116

13.47

122.99

1.0

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

140

142

10.11

122.88

3.6

1.8

ug/l

42.0

60.9

1.55

140

137

(36304419) Bacteria [Presence] in Urine

1999

12273

2.03

122.85

4.8

3.3

—

(3024471) HLA-A [Type]

117

13.14

122.23

1.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

751

3072

2.69

121.23

5.9

3.8

mmol/l

2.3

1.8

2.87

595

2237

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

775

3222

2.66

121.12

6.2

3.8

kpa

5.2

0.04

732

2957

(3009343) pH of Capillary blood

766

3178

2.66

120.15

6.1

3.8

7.4

3.87

132

388

(3011412) CD3 cells [#/volume] in Blood

210

352

6.18

119.97

2.2

2.0

e9/l

1.0

1.1

1.75

150

205

(3017143) Hepatitis C virus Ab [Presence] in Serum

801

3405

2.60

119.55

1.6

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

2191

14004

1.99

119.15

5.0

3.5

e6/l

103.0

95.8

0.05

1779

10970

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

386

1080

3.78

118.55

1.6

iu/ml

65.9

6.4

0.89

249

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1377

7459

2.16

117.45

6.7

3.1

mmol/l

0.8

0.88

1288

6900

(3036481) Cortisol [Moles/volume] in Serum or Plasma

819

3560

2.55

116.49

2.1

2.2

nmol/l

344.6

374.8

2.88

770

3243

(3030467) Casts [#/volume] in Urine by Automated count

2039

12798

1.99

116.01

4.9

3.3

e6/l

0.4

0.5

0.53

1613

9827

(1616796) Gas panel - Central venous blood

384

1091

3.73

115.26

5.4

3.8

—

(3018095) Leukocytes [#/volume] in Urine

2382

15838

1.95

113.79

6.1

3.9

e6/l

87.4

112.8

0.55

1840

11672

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

167

233

7.38

113.50

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

167

233

7.38

113.50

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

167

233

7.38

113.50

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

167

236

7.28

112.20

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

167

236

7.28

112.20

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

167

236

7.28

112.20

1.3

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2802

19746

1.93

111.58

6.4

4.8

g/l

33.4

34.7

28.66

2618

18202

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

830

3704

2.48

111.25

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

173

261

6.83

109.45

2.1

2.0

16.7

14.1

0.93

110

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

382

1140

3.54

106.34

3.3

2.4

g/l

3.8

3.6

2.22

375

1075

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

205

379

5.59

105.67

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

205

379

5.59

105.67

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

205

379

5.59

105.67

1.6

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

181

301

6.20

104.16

1.4

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

729

3178

2.51

102.18

8.5

6.6

mmol/l

25.1

24.5

3.87

697

2956

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

936

4566

2.29

101.78

4.3

3.0

ng/l

241.1

235.4

0.14

879

4191

(3020779) Urea [Moles/volume] in Serum or Plasma

925

4497

2.29

101.36

11.7

6.8

mmol/l

10.6

11.0

1.02

883

4258

(3015235) Bicarbonate [Moles/volume] in Capillary blood

413

1334

3.28

101.33

4.9

3.0

mmol/l

25.3

24.9

0.84

378

1154

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

166

260

6.57

101.31

2.2

2.0

—

(3000850) Epithelial cells [#/volume] in Urine

1646

9955

1.97

101.13

3.9

2.7

e6/l

4.6

4.7

0.01

1485

8727

(3023420) DNA double strand Ab [Units/volume] in Serum

189

338

5.77

100.91

2.0

1.3

iu/ml

22.3

25.9

—

(3026782) Osmolality of Urine

1562

9292

1.98

100.60

4.0

2.9

mosm/kgh2o

535.6

553.6

3.17

1393

7914

(3010375) cycloSPORINE [Mass/volume] in Blood

128

151

8.67

100.16

45.6

23.1

ug/l

159.4

111.2

6.65

104

124

(3032080) INR in Blood by Coagulation assay

2743

19646

1.86

99.12

12.6

10.9

inr

1.3

2.84

907

5341

(3027315) Oxygen [Partial pressure] in Blood

359

1077

3.51

99.00

7.1

4.6

kpa

8.2

8.4

1.73

352

1052

(40767503) Oxygen content in Capillary blood by calculation

354

1054

3.53

98.76

3.5

2.5

16.0

0.01

194

559

(3013826) Glucose [Moles/volume] in Serum or Plasma

3410

26206

1.91

98.14

8.6

4.9

mmol/l

6.8

6.9

0.55

3291

24670

(3009871) Measles virus Ab [Titer] in Serum

13.18

96.48

1.3

1.6

—

(3012501) Base excess in Blood by calculation

354

1070

3.48

96.45

7.1

4.6

mmol/l

2.8

2.7

0.23

267

728

(3013290) Carbon dioxide [Partial pressure] in Blood

354

1071

3.48

96.31

7.1

4.6

kpa

5.0

0.01

347

1047

(3021901) Oxygen saturation in Capillary blood

334

981

3.57

95.08

4.6

2.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

132

173

7.81

94.69

1.4

1.1

—

(40757373) Influenza virus identified in Isolate

102

10.71

93.60

2.9

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

223

494

4.67

93.28

1.3

1.2

u/ml

2.2

3.8

0.98

152

(3028626) Oxygen [Partial pressure] in Capillary blood

375

1203

3.29

92.87

5.9

3.3

kpa

7.8

8.0

1.66

358

1116

(3010421) pH of Blood

384

1251

3.24

92.72

6.9

4.4

7.4

0.95

347

1048

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

238

562

4.39

91.87

1.2

u/ml

350.9

291.0

1.18

156

330

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

166

289

5.90

91.12

2.2

2.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

163

279

6.00

91.05

1.1

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1300

7476

1.99

90.74

2.9

2.6

umol/l

11.5

12.3

4.20

1234

6867

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1178

6542

2.04

90.71

2.9

2.6

20.7

22.0

2.67

1001

5504

(3000991) Gas panel - Venous blood

828

4019

2.27

90.21

12.0

7.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1229

6950

2.01

89.86

2.8

2.6

g/l

2.2

2.3

0.59

1147

6396

(4306422)

208

450

4.78

89.53

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

109

121

9.18

89.41

40.9

31.8

ug/l

8.0

7.2

1.96

108

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

205

439

4.82

89.33

1.2

1.1

118.6

114.4

0.86

198

393

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2401

16870

1.80

88.80

2.9

2.2

nmol/l

77.5

79.1

2.08

2213

14741

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

354

1132

3.29

88.04

3.5

2.2

89.8

88.9

0.28

341

1077

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

214

481

4.60

87.90

1.3

1.2

u/ml

3.4

5.2

1.13

130

208

(3014576) Chloride [Moles/volume] in Serum or Plasma

1108

6084

2.05

87.66

11.8

6.6

mmol/l

103.9

104.4

2.94

1079

5936

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

245

616

4.13

87.03

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

163

294

5.69

86.20

2.2

2.0

31.6

40.8

1.05

(3014148) Varicella zoster virus Ab [Titer] in Serum

158

287

5.65

82.92

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1043

5713

2.04

82.51

4.6

4.1

u/l

270.0

245.5

4.45

989

5375

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

156

285

5.61

81.37

1.3

1.2

titre

122.0

117.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

156

285

5.61

81.37

1.3

1.2

titre

132.0

137.4

0.03

(3037467) Urinalysis macro (dipstick) panel - Urine

3617

29122

1.83

80.44

6.9

4.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

167

331

5.18

79.61

1.4

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

325

1048

3.24

79.60

3.7

2.4

211.5

201.7

1.04

309

1000

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

198

456

4.48

78.84

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

168

343

5.03

77.40

1.2

95.9

94.3

0.28

163

321

(3014111) Lactate [Moles/volume] in Serum or Plasma

824

4228

2.13

77.20

11.1

6.6

mmol/l

1.5

1.4

1.69

789

4055

(3048929) Epstein Barr virus Ab [Presence] in Serum

272

807

3.50

76.03

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

164

334

5.04

75.77

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

373

1344

2.92

75.30

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

589

2669

2.36

74.53

14.8

9.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1465

9251

1.82

74.24

5.3

4.0

ng/l

455.3

506.4

0.17

1298

7873

(3028433) Virus identified in Specimen by Culture

101

130

7.91

73.55

1.1

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1660

10938

1.77

72.49

6.4

4.1

84.8

85.1

0.16

1633

10679

(3004588) Protein electrophoresis panel - Serum or Plasma

716

3570

2.17

71.84

2.1

2.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1073

6202

1.92

71.51

7.9

5.7

mmol/l

1.1

1.0

0.99

1004

5716

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

310

1039

3.11

71.04

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

310

1039

3.11

71.04

1.5

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

15.30

70.82

1.5

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

813

4283

2.07

70.52

2.2

2.6

g/l

66.3

66.0

0.38

749

3851

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

128

7.79

70.48

2.0

1.9

—

(3036489) Thrombin time

385

1461

2.77

70.45

3.4

2.0

21.8

21.7

0.10

352

1319

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2004

14027

1.71

69.81

3.5

2.2

u/l

148.6

226.2

5.08

1893

13075

(4268621)

155

323

4.92

69.71

2.3

—

(3002032) Base excess in Venous blood by calculation

855

4620

2.02

69.04

4.8

3.8

mmol/l

2.3

1.9

1.63

714

3704

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

132

241

5.60

68.88

1.6

1.3

u/ml

1.0

1.3

0.16

121

(3021447) Carbon dioxide [Partial pressure] in Venous blood

854

4625

2.02

68.48

4.8

3.8

kpa

5.9

5.8

1.07

822

4476

(3028271) Lactate [Moles/volume] in Capillary blood

253

768

3.41

68.18

2.4

1.9

mmol/l

1.7

0.36

247

747

(3035350) Ketones [Presence] in Urine by Test strip

2669

20238

1.67

67.95

5.0

3.9

estimate

0.0

0.50

707

3735

(3022313) Gas panel - Capillary blood

515

2288

2.39

67.88

6.5

4.0

—

(3012544) pH of Venous blood

871

4791

1.99

66.67

4.8

3.8

7.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

691

3495

2.13

66.51

1.9

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

130

242

5.49

66.43

2.1

2.0

e6/l

450.6

521.9

0.65

110

199

(3021601) Nitrite [Presence] in Urine by Test strip

2660

20254

1.66

65.77

6.7

5.3

estimate

0.0

0.50

719

3771

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

625

3052

2.19

65.75

2.0

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1727

11760

1.71

65.57

5.0

2.8

umol/l

1984.7

5669.3

5.53

1527

9971

(3015377) Calcium [Moles/volume] in Serum or Plasma

2110

15178

1.67

64.90

4.3

3.4

mmol/l

2.3

2.59

1903

12968

(21494814) CD8 cells/100 lymphocytes in Specimen

144

6.99

64.74

2.0

1.9

—

(3017569) Oxygen content in Arterial blood

131

253

5.29

64.29

2.2

2.0

—

(3009261) Glucose [Presence] in Urine by Test strip

2681

20526

1.65

64.26

5.0

4.0

estimate

0.0

1.34

702

3652

(3031040) Bacteria [#/volume] in Urine by Automated count

3477

28464

1.70

64.05

6.5

4.9

e6/l

805.0

1865.0

1.21

477

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1195

7378

1.81

63.68

4.2

3.2

e6/l

1.6

2.0

1.09

674

4208

(3027945) Reticulocytes/100 erythrocytes in Blood

1014

5986

1.87

62.33

3.6

2.4

1.9

1.8

4.99

900

5254

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

122

228

5.46

62.08

2.2

2.0

e9/l

0.2

0.25

108

197

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

782

4253

1.99

61.42

2.2

g/l

0.2

1.61

731

3940

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

580

2828

2.19

61.02

1.7

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

615

3079

2.13

60.45

14.2

8.5

92.4

93.9

7.24

609

3066

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

121

231

5.34

60.15

1.7

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

231

5.34

60.15

1.7

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

121

231

5.34

60.15

1.7

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

117

221

5.40

58.85

2.2

1.6

u/l

6.0

6.8

0.41

103

188

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

104

176

6.01

58.76

1.7

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

104

176

6.01

58.76

1.7

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

8.91

58.75

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

111

202

5.60

58.13

1.1

1.2

—

(3034426) Prothrombin time (PT)

109

7.63

58.09

1.1

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

104

178

5.94

58.08

1.7

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

119

231

5.25

58.07

1.7

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

494

2301

2.27

58.02

4.9

4.0

mmol/l

24.4

24.1

1.19

445

2053

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.88

56.99

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

600

3071

2.08

55.40

14.5

8.5

0.6

0.7

0.71

594

3044

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

8.56

55.39

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

3774

32077

1.68

55.06

37.9

20.5

14.3

13.9

50.86

3748

31298

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1161

7386

1.74

54.64

2.9

2.0

30.0

30.2

0.54

1135

7158

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

702

3823

1.97

54.46

4.7

4.1

mmol/l

1.2

1.92

641

3337

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

599

3087

2.07

54.23

14.4

8.4

1.4

1.3

1.44

593

3065

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1220

7898

1.72

53.79

3.9

3.0

e6/l

0.9

1.2

2.11

702

4685

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2195

16626

1.56

50.40

3.4

2.9

ug/l

200.9

154.8

6.52

2010

15058

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2320

17863

1.55

49.05

5.2

4.1

ng/l

39.9

89.0

1.26

1845

13644

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

399

1826

2.29

48.62

4.1

2.9

u/ml

0.3

1.22

246

1040

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

108

225

4.88

48.61

2.5

2.6

39.5

36.4

0.65

(3019977) pH of Arterial blood

123

285

4.40

48.59

2.6

2.4

7.4

0.29

(3023520) Reticulocytes [#/volume] in Blood

779

4553

1.84

48.26

3.4

2.5

e9/l

73.5

68.0

2.98

538

3482

(4015189)

121

6.53

48.03

1.9

2.1

—

(3015736) pH of Urine

2100

15867

1.55

48.03

4.3

3.7

—

5.8

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

143

385

3.79

46.12

1.1

iu/ml

1.7

2.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1660

11998

1.57

45.66

2.6

2.3

mg/l

3.2

3.0

2.35

1458

10133

(3006245) CD3-CD19+ cells/100 cells in Blood

121

6.36

45.65

2.2

2.0

9.0

12.4

1.13

107

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

429

2089

2.15

44.77

5.5

5.0

1.8

1.6

3.04

405

1955

(3020891) Body temperature

412

1984

2.17

44.22

5.8

4.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

222

812

2.81

43.33

1.4

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

795

4831

1.76

42.83

3.1

2.7

umol/l

10.1

9.3

0.41

699

4223

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2503

20072

1.49

40.73

3.0

2.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

654

3807

1.82

40.57

3.9

3.2

kpa

4.5

0.19

626

3670

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

8.72

40.49

1.3

1.2

—

(40761536) Microorganisms panel - Urine sediment

615

3515

1.85

40.47

5.4

4.2

—

(3047181) Lactate [Moles/volume] in Blood

334

1531

2.26

40.40

7.8

5.9

mmol/l

1.4

1.3

0.86

312

1355

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

178

4.96

40.03

1.1

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

162

519

3.19

39.96

1.1

g/l

1.6

0.16

144

462

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

105

254

4.20

39.26

2.3

1.9

e6/l

645.9

604.2

0.21

108

(4035726)

658

3879

1.80

39.06

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

212

801

2.72

38.88

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

9.65

38.57

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

161

5.10

38.54

1.1

1.2

ratio

1.1

0.02

(3024891) Influenza virus A+B Ag [Presence] in Specimen

233

937

2.56

37.70

1.3

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

352

1698

2.15

37.49

3.6

2.2

ug/l

332.2

628.8

1.54

335

1609

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

775

4844

1.71

37.34

4.9

3.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4407

40177

1.72

37.15

34.5

16.9

mg/l

24.9

26.7

4.14

4134

32712

(3052851) Hemolysis interference index of Serum or Plasma

305

1398

2.26

36.86

4.2

3.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

137

418

3.34

36.61

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

351

1707

2.13

36.60

2.6

3.3

mg/l

63.0

95.8

0.49

254

1413

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

350

1704

2.13

36.39

2.6

3.3

mg/l

44.7

57.5

0.77

253

1413

(3037756) Immunofixation for Serum or Plasma

263

1138

2.38

36.33

1.5

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

122

5.64

36.21

1.1

u/ml

27.9

6.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

343

1666

2.14

35.87

2.6

3.3

ratio

3.0

3.8

0.20

119

(3044889) 12 lead EKG panel

3413

29519

1.47

35.09

5.8

4.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

218

879

2.55

35.08

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

384

1970

2.03

34.67

7.4

4.3

mmol/l

25.1

24.8

1.45

364

1794

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

453

2462

1.92

34.62

1.9

1.7

g/l

1.6

0.53

383

2108

(3007930) Methemoglobin/Hemoglobin.total in Blood

397

2066

2.00

34.43

5.9

5.1

0.9

0.11

372

1937

(3039000) Anion gap in Blood

252

1106

2.34

33.70

7.4

6.8

mmol/l

11.8

11.2

1.58

232

987

(3018572) Chloride [Moles/volume] in Blood

252

1106

2.34

33.70

7.4

6.8

mmol/l

103.9

105.1

4.11

232

987

(3046861) Legionella sp Ag [Presence] in Urine

13.55

33.08

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

130

412

3.21

32.69

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1422

10526

1.49

32.60

5.0

3.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

351

1791

2.03

32.13

4.9

3.7

mmol/l

1.4

0.39

346

1759

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

365

1893

2.00

31.92

2.4

2.3

g/l

3.3

3.1

3.40

292

1475

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

310

1515

2.11

31.86

2.4

2.3

g/l

0.1

0.0

0.41

287

1375

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

293

1408

2.15

31.45

2.5

2.3

g/l

0.0

0.50

270

1273

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

386

2052

1.95

31.43

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

386

2053

1.95

31.38

2.4

2.3

g/l

7.8

7.4

3.56

295

1496

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

385

2049

1.95

31.24

2.4

2.3

g/l

3.9

3.8

0.52

288

1443

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

221

947

2.39

31.20

1.9

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

288

1382

2.15

31.02

2.5

2.3

g/l

0.0

0.00

270

1267

(3004809) Band form neutrophils/100 leukocytes in Blood

202

833

2.48

31.01

4.1

3.6

1.6

1.5

0.12

175

619

(3011397) Hemoglobin [Presence] in Urine by Test strip

1333

9828

1.48

30.87

4.3

3.9

—

(3029937) Albumin [Presence] in Urine by Test strip

1487

11203

1.46

30.82

5.5

4.3

estimate

0.0

0.88

668

3570

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1770

13779

1.44

30.80

3.0

2.6

u/l

63.0

58.3

0.71

1644

12655

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

365

1919

1.97

30.68

2.4

2.3

g/l

10.7

10.3

0.92

310

1607

(3007853) Bacteria identified in Skin by Aerobe culture

783

5164

1.61

30.08

2.1

1.8

—

(3021788) Differential panel - Synovial fluid

197

821

2.46

29.57

1.6

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1191

8683

1.48

28.86

2.9

3.1

mmol/l

2.5

7.77

1068

7568

(3026008) Bacteria identified in Urine by Culture

1781

14009

1.42

28.73

3.7

3.4

—

(3029075) Extractable nuclear Ab panel - Serum

5.84

28.32

1.1

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

330

1725

1.98

28.17

2.4

g/l

0.7

1.0

1.14

295

1466

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

308

1585

2.00

27.48

2.4

2.2

g/l

35.8

37.4

4.26

280

1337

(40760888) Immunoglobulin light chains.free panel - Serum

263

1280

2.11

27.30

2.5

3.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

134

4.67

26.81

1.3

2.2

199.6

167.3

1.30

125

(40768797) Stomach Pathology biopsy report

849

5848

1.54

26.73

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

219

1005

2.23

26.37

1.2

titre

885.0

1046.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

217

998

2.23

25.99

1.3

1.2

titre

120.0

91.4

0.44

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

5.69

25.96

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

146

570

2.61

25.16

1.2

1.3

miu/ml

209.5

209.7

0.00

205

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

147

577

2.59

25.06

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

5.50

25.03

1.1

89.8

82.5

0.70

(3004119) Hemoglobin [Mass/volume] in Venous blood

490

3010

1.69

24.62

4.6

3.3

g/l

126.2

127.5

0.65

474

2933

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2829

24453

1.35

23.87

4.4

3.2

u/l

64.9

55.2

3.53

2632

22240

(3051651) Icteric interference index of Serum or Plasma

270

3.30

23.42

5.3

3.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

5.26

23.39

1.1

1.3

91.5

80.8

0.94

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

248

1261

2.02

22.88

1.5

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1897

15511

1.36

22.68

5.3

4.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

283

1513

1.92

22.58

5.6

3.9

mmol/l

4.0

3.9

2.10

258

1404

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

226

1118

2.07

22.48

3.6

3.0

mg/l

1.8

1.7

1.02

208

1003

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.04

22.29

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

595

3939

1.58

22.05

2.8

2.4

u/l

35.7

38.5

0.62

539

3346

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1016

7538

1.43

21.60

1.3

1.2

u/ml

1.1

1.7

2.77

253

1855

(3003327) Ova and parasites identified in Stool by Light microscopy

214

1055

2.07

21.49

1.9

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

134

545

2.50

21.26

1.4

mmol/l

6.6

6.4

0.24

120

508

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

101

360

2.84

20.81

1.8

1.7

mg/l

4.7

0.03

343

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

275

1507

1.87

20.35

1.4

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

32.66

20.16

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

5.23

19.82

2.4

2.0

e6/l

133.7

1525.9

0.58

(3027273) Bicarbonate [Moles/volume] in Venous blood

401

2473

1.67

19.75

4.4

3.5

mmol/l

25.6

25.1

1.78

383

2391

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

537

3569

1.56

19.46

1.7

1.6

1.41

451

3020

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

112

4.32

18.95

2.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

108

421

2.60

18.76

1.9

1.4

38.7

26.1

2.69

270

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

368

2256

1.68

18.52

4.0

2.7

0.7

0.6

1.10

360

2157

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

128

544

2.39

18.51

1.7

1.5

58.7

62.0

0.40

355

(3045716) Anion gap in Serum or Plasma

227

3.20

18.41

2.3

2.2

mmol/l

8.4

9.3

1.15

177

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

108

427

2.56

18.23

1.3

u/l

15.4

12.6

0.57

390

(3008757) Leukocyte morphology finding [Identifier] in Blood

126

537

2.38

18.11

4.7

4.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1422

11445

1.34

17.85

1.8

1.6

nmol/l

18.8

20.1

2.77

1270

9687

(3017732) Neutrophils [#/volume] in Blood

422

2707

1.61

17.75

3.3

e9/l

4.5

4.2

1.36

334

1943

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

4.42

17.50

1.7

1.4

ug/l

7.7

9.4

1.71

(40768804) Tissue Pathology biopsy report

1977

16693

1.30

17.49

2.4

2.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

127

554

2.33

17.34

1.3

u/l

488.4

326.7

1.59

116

523

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.34

17.28

1.2

1.4

—

(3004451) EKG impression Narrative

259

2.96

17.05

1.4

1.3

—

(3025941) Bacteria identified in Stool by Culture

339

2080

1.67

17.00

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

208

1108

1.91

16.82

1.8

1.6

e6/l

15431.4

15207.7

0.02

156

795

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

146

685

2.16

16.74

1.2

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

205

3.20

16.64

1.7

1.4

3.7

4.2

0.14

(3044242) Glucose [Moles/volume] in Arterial blood

276

2.85

16.37

1.6

1.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1231

9822

1.33

16.11

1.9

1.8

nmol/l

1169.8

1163.6

0.08

931

7327

(3012441) Differential panel - Pleural fluid

133

611

2.21

16.08

1.5

—

(3045142) Bone marrow Pathology biopsy report

123

547

2.28

16.08

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

338

2103

1.65

16.06

2.6

1.9

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.27

16.05

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

122

544

2.27

15.86

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

248

1425

1.78

15.76

1.4

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

190

1006

1.92

15.66

2.8

2.5

umol/l

33.7

34.8

0.22

167

831

(3024928) Oxygen saturation in Venous blood

188

995

1.92

15.52

4.1

3.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

401

2.47

15.46

1.6

1.4

u/l

14.7

13.2

1.07

382

(3000093) Morphology [Interpretation] in Blood Narrative

109

469

2.35

15.40

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

224

1260

1.81

15.29

1.6

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

152

753

2.05

15.15

3.1

3.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

233

2.94

15.15

4.1

3.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.52

15.15

1.4

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

172

891

1.96

15.13

1.7

1.5

—

(40768446) Kidney Pathology biopsy report

133

3.63

15.05

1.4

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

159

808

2.00

14.78

1.5

g/l

32.0

31.4

0.21

136

724

(3026389) Candida sp identified in Specimen by Organism specific culture

117

529

2.24

14.74

1.5

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

103

443

2.35

14.58

1.1

1.2

u/l

58.7

61.4

0.18

294

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.72

14.41

1.1

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

110

491

2.27

14.30

4.9

3.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

5.11

14.08

1.0

1.2

93.4

76.0

—

(3044941) Cell count panel - Synovial fluid

145

727

2.02

14.02

1.7

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

563

4041

1.44

13.88

2.3

2.1

ug/g

186.1

164.7

0.55

461

3131

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

510

3605

1.46

13.62

4.3

3.8

ng/l

108.2

96.0

1.34

444

3043

(40768795) Lymph node Pathology biopsy report

395

2.38

13.57

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

496

3501

1.46

13.34

3.8

2.8

ml/min/173m2

55.7

61.5

3.30

240

1485

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.36

13.31

1.6

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3253

29766

1.26

13.15

4.1

3.9

pmol/l

14.9

15.0

0.65

2941

26512

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.93

13.08

1.1

1.2

77.0

81.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

4.45

12.82

1.8

mg/l

6.5

8.9

1.39

(40768806) Pleura Pathology biopsy report

125

618

2.05

12.60

1.5

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

5.97

12.58

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.81

12.29

1.2

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.81

12.29

1.2

1.0

—

(3045788) Cell count panel - Pleural fluid

114

551

2.09

12.21

1.6

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

129

657

1.99

11.99

7.5

6.4

mg/l

12.0

12.1

0.20

121

604

(3023430) Cat dander IgE Ab [Units/volume] in Serum

225

2.73

11.95

1.0

1.1

u/ml

1.6

3.6

0.93

(3027456) Digoxin [Moles/volume] in Serum or Plasma

201

1181

1.73

11.88

3.0

3.1

nmol/l

0.9

0.8

0.37

160

888

(3010726) Horse dander IgE Ab [Units/volume] in Serum

290

2.50

11.84

1.1

u/ml

2.6

1.4

0.43

(44806071)

5.85

11.78

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

304

2.46

11.67

1.4

1.2

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

9.36

11.65

1.6

1.1

mg/l

0.9

1.1

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

9.36

11.65

1.6

1.1

mg/l

6.2

1.8

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

9.36

11.65

1.6

1.1

mg/l

6.2

1.4

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

9.36

11.65

1.6

1.1

mg/l

1.6

4.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

9.36

11.65

1.6

1.1

mg/l

3.4

3.0

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

9.36

11.65

1.6

1.1

mg/l

2.6

4.0

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

9.36

11.65

1.6

1.1

mg/l

2.8

0.7

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

9.36

11.65

1.6

1.1

mg/l

1.3

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2253

19958

1.23

11.62

5.1

4.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

246

2.62

11.58

1.0

1.1

u/ml

3.5

2.6

0.21

100

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

394

2.26

11.44

1.1

u/ml

1.6

2.2

0.26

160

(3012516) Albumin [Mass/volume] in Urine

1646

14120

1.24

11.39

3.7

3.2

mg/l

721.2

300.7

2.22

1102

9036

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.02

11.33

1.3

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2180

19289

1.23

11.23

2.2

2.1

pmol/l

90.9

93.0

1.31

1199

10084

(40761511) CBC panel - Blood by Automated count

4305

41024

1.32

11.15

26.9

16.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

214

1302

1.67

11.15

1.4

1.5

ug/g

296.4

264.1

0.48

129

785

(3013727) Leukocytes other/100 leukocytes in Blood

173

2.91

11.05

4.4

3.6

59.3

55.2

0.63

166

(3009508) Creatinine [Moles/volume] in Urine

1674

14431

1.24

10.98

3.6

3.2

mmol/l

7.1

7.3

1.44

1393

11890

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

259

2.53

10.96

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

259

2.53

10.96

1.5

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

271

2.49

10.95

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

295

1951

1.54

10.88

2.3

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.27

10.57

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

345

2.28

10.47

1.1

u/ml

4.0

3.5

0.12

162

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

113

578

1.98

10.43

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

126

671

1.90

10.34

1.1

1.2

—

(3000012) Reticulocyte production index

275

2.42

10.15

2.0

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

289

2.37

10.02

1.4

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4411

42301

1.32

9.98

35.5

20.1

mmol/l

139.0

139.6

40.33

4363

41179

(3020682) Albumin/Creatinine [Ratio] in Urine

1712

14912

1.22

9.92

4.5

4.0

mg/mmol

12.8

9.5

1.72

1112

9463

(3040151) Glucose [Moles/volume] in Capillary blood

112

583

1.94

9.85

12.8

20.2

mmol/l

7.5

0.02

482

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

197

2.66

9.74

1.0

u/ml

0.2

0.3

0.21

(3017704) Immunofixation for Urine

295

2.32

9.58

1.3

1.5

—

(40768443) Skin Pathology biopsy report

286

1936

1.51

9.49

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4412

42376

1.31

9.38

35.8

20.3

mmol/l

4.0

2.78

4358

41191

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.68

9.28

1.0

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

250

2.42

9.26

1.1

1.2

u/l

46.6

22.2

1.62

209

(3035880) pH of Pleural fluid

325

2.23

9.26

1.3

—

(3044927) Protein electrophoresis panel - Urine

105

548

1.94

9.19

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

158

2.80

9.15

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.98

9.04

1.2

ng/l

117.7

1378.8

0.50

(3008401) Mugwort IgE Ab [Units/volume] in Serum

335

2.20

9.03

1.1

u/ml

0.5

1.5

1.34

144

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

168

1017

1.67

8.99

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

568

4381

1.33

8.95

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

591

4589

1.33

8.89

2.6

2.4

ug/l

11.6

6.9

4.30

521

3944

(3023199) Leukocytes [#/volume] in Pleural fluid

127

713

1.80

8.87

1.6

1.5

e6/l

5608.3

1625.1

0.70

515

(3009542) Hematocrit [Volume Fraction] of Blood

3697

34863

1.22

8.86

34.4

18.3

38.8

38.9

0.03

2402

22052

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

262

2.34

8.82

1.1

1.2

u/l

97.4

86.7

0.41

224

(3022493) Free Hemoglobin [Mass/volume] in Plasma

192

2.57

8.63

6.7

4.7

mg/l

63.3

70.3

0.39

133

(3028308) Erythrocytes [#/volume] in Pleural fluid

117

648

1.82

8.56

1.5

1.4

e6/l

126774.0

66101.3

0.63

381

(36660697) Celiac disease serology panel - Serum

378

2757

1.40

8.48

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4408

42444

1.29

8.38

36.4

20.1

umol/l

87.9

83.5

7.86

4408

42433

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

207

2.48

8.36

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

207

2.48

8.36

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

139

2.82

8.25

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

521

1.90

8.17

4.5

3.5

55.2

59.4

0.96

313

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3838

36423

1.22

8.16

5.1

4.7

mu/l

2.1

0.09

3509

32591

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

125

2.89

7.99

1.1

u/ml

14.3

2.1

1.10

(3006922) Hepatitis E virus Ab [Presence] in Serum

219

2.39

7.90

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1176

10070

1.22

7.71

1.8

1.7

pmol/l

31870905.2

29499384.3

0.04

957

8163

(3036603) Volume of Urine

294

2.16

7.54

1.4

1.8

1864.2

1797.5

0.13

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4395

42414

1.26

7.43

21.0

11.1

u/l

24.6

25.6

3.11

4341

40567

(3023383) Lactate [Moles/volume] in Pleural fluid

177

2.50

7.39

1.3

mmol/l

3.9

3.4

0.43

161

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

109

2.95

7.37

5.3

2.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

271

2.19

7.36

1.4

1.6

u/l

9.3

6.4

0.60

126

(3006576) Bicarbonate [Moles/volume] in Blood

149

2.63

7.27

5.9

7.4

mmol/l

24.2

24.7

0.24

135

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

7.71

7.12

1.9

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

1585

14043

1.19

7.09

3.2

2.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

123

2.78

7.04

1.3

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3947

37719

1.21

7.02

29.2

16.1

ml/min/173m2

73.4

74.2

1.74

3546

31281

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3958

37841

1.21

6.97

7.0

6.5

mmol/mol

41.5

40.8

3.44

3682

34411

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

486

1.85

6.89

2.7

3.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

313

2.06

6.83

1.2

1.0

—

(3022145) Colonoscopy Study observation

577

4629

1.28

6.76

1.4

1.3

—

(3003181) Sodium [Moles/volume] in Urine

137

851

1.63

6.73

1.4

1.3

mmol/l

66.1

62.7

0.47

124

681

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.46

6.70

1.3

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

458

5803

0.77

6.61

9.6

8.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.16

6.54

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.16

6.54

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.16

6.54

1.3

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

423

1.88

6.53

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

441

5598

0.77

6.46

4.7

4.8

32.0

33.2

1.36

319

3640

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.47

6.28

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

138

879

1.59

6.15

1.1

u/ml

21.7

9.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

337

1.94

5.95

1.7

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

334

2535

1.34

5.90

2.6

2.5

—

(21494434) Karyotype in Bone marrow

438

1.82

5.89

1.3

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.82

5.82

1.3

1.5

3.9

6.3

0.60

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

622

5123

1.24

5.81

3.1

4.0

ug/l

15.0

23.1

0.79

512

4227

(3022217) INR in Platelet poor plasma by Coagulation assay

837

7110

1.21

5.81

28.9

29.0

inr

1.4

1.5

0.28

1004

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

11.13

5.79

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

108

2.69

5.74

1.2

mmol/l

1.9

1.5

0.89

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

342

1.91

5.71

1.7

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

181

2.28

5.70

1.1

iu/ml

7.6

14.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.88

5.61

1.4

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.54

5.59

1.3

1.0

iu/ml

6.2

6.9

0.09

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

4.25

5.55

1.3

ml/s/173m2

0.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

191

2.21

5.46

1.5

1.3

2.5

0.80

161

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.47

5.44

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

253

2.03

5.32

1.8

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

253

2.03

5.32

1.8

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

425

1.78

5.25

1.2

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

156

2.32

5.25

3.5

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

156

2.32

5.25

3.5

2.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

114

2.55

5.20

6.3

7.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.13

5.18

1.3

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

125

812

1.55

5.18

1.2

1.3

u/l

48.9

41.4

0.16

108

700

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

216

2.09

5.13

1.2

1.1

u/l

35.2

36.4

0.03

158

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

216

2.09

5.13

1.2

1.1

u/l

92.8

94.2

0.03

160

(3020491) Glucose [Moles/volume] in Blood

313

1.90

5.10

2.1

2.3

mmol/l

7.4

6.8

0.87

206

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1212

10746

1.17

5.09

3.1

2.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

286

1.93

5.05

1.0

mg/l

293.2

284.7

0.38

251

(3011648) Oxygen content in Venous blood

359

1.82

4.97

6.0

2.3

10.9

10.8

0.07

359

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

111

2.53

4.95

1.6

1.5

ug/l

0.3

0.5

0.84

(3044416) Complement C4 [Mass/volume] in Pleural fluid

4.07

4.89

1.1

g/l

0.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.22

4.88

1.3

1.1

—

(3012565) Volume of 24 hour Urine

214

2.07

4.87

1.7

2.5

1981.0

1873.8

0.36

178

(44813793)

214

2.07

4.87

1.1

1.0

—

(3045424) Erythrocytes [Presence] in Urine

111

713

1.57

4.86

1.8

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.17

4.75

1.3

nmol/l

11.7

168092.5

0.49

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

269

2049

1.33

4.70

2.5

3.3

pmol/l

4.3

4.4

1.03

230

1780

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

232

1.99

4.63

1.4

1.5

62.9

67.4

0.29

190

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

115

2.44

4.62

1.4

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

143

984

1.47

4.56

1.6

1.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

8.19

4.56

1.1

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

8.19

4.56

1.1

1.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

163

1152

1.43

4.52

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

162

1146

1.43

4.47

1.3

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

556

1.61

4.41

1.5

2.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

169

2.14

4.39

1.3

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.73

4.34

1.3

14.4

19.6

0.26

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

160

1136

1.42

4.34

1.3

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.99

4.12

1.3

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.80

4.11

1.5

1.4

69.2

74.6

0.31

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.08

4.08

1.1

1.6

—

(3016750) Collection duration of Urine

281

1.82

4.00

2.3

2.0

min

471.6

492.6

0.61

198

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

149

2049

0.72

3.85

1.9

1.8

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

592

1.55

3.85

1.6

1.4

—

(3024263) Appearance of Synovial fluid

263

1.83

3.84

2.1

1.6

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

146

2.13

3.79

1.2

1.4

21.6

22.6

0.07

121

(3005011) Chlamydia sp Ab [Titer] in Serum

3.19

3.77

1.4

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

259

1.82

3.71

1.9

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

598

1.53

3.69

1.6

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

169

2.02

3.63

2.8

2.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

211

1.90

3.62

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

593

1.53

3.62

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

593

1.53

3.62

1.6

1.4

—

(3016038) Potassium [Moles/volume] in Urine

313

1.73

3.61

1.3

1.1

mmol/l

32.9

34.8

0.28

264

(3005988) Vibrio sp identified in Specimen by Organism specific culture

595

1.52

3.57

1.6

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

605

1.51

3.52

1.6

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1196

10853

1.13

3.47

1.7

1.6

mmol/l

1.4

1.3

3.99

986

9002

(3024731) MCV [Entitic volume]

4464

43705

1.17

3.44

45.2

24.8

92.5

91.6

25.79

4428

42890

(3002523) Influenza virus A Ag [Presence] in Specimen

348

1.67

3.44

1.2

1.1

—

(3035941) MCH [Entitic mass]

4464

43706

1.17

3.44

45.1

24.7

30.5

30.4

0.64

4429

42891

(3026361) Erythrocytes [#/volume] in Blood

4464

43708

1.17

3.43

45.3

24.8

e12/l

4.4

12.84

4379

42207

(3007461) Platelets [#/volume] in Blood

4463

43698

1.17

3.42

45.4

24.8

e9/l

245.1

240.9

3.65

4393

42371

(3038071) Oxygen [Partial pressure] in Mixed venous blood

100

2.31

3.42

5.9

8.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

209

1.87

3.38

1.5

1.3

—

(3010813) Leukocytes [#/volume] in Blood

4464

43716

1.17

3.38

45.4

24.9

e9/l

7.8

6.9

60.04

4382

42208

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

107

2.25

3.38

1.0

1.1

miu/ml

1772.8

1678.8

0.12

107

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

174

1.96

3.37

1.2

1.3

ug/l

136.4

466.8

0.73

(3000963) Hemoglobin [Mass/volume] in Blood

4464

43717

1.17

3.37

45.7

25.0

g/l

131.4

133.8

19.68

4428

42915

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.92

3.29

1.9

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

449

1.57

3.21

1.8

1.3

e6/l

100723.5

113080.6

0.06

312

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.86

3.18

4.1

4.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

349

1.64

3.16

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1312

0.69

3.16

1.6

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

448

3811

1.19

3.08

1.7

1.6

—

(21494755) Public health laboratory ask at order entry panel

127

1722

0.73

3.08

1.3

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.89

3.02

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

190

1.85

2.96

1.1

1.6

umol/l

5.7

12.1

1.13

125

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.64

2.96

1.6

1.2

ug/l

109.7

121.9

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.28

2.93

1.3

1.2

mmol/l

0.5

2.0

1.27

(3003694) ABO and Rh group [Type] in Blood

1130

10323

1.12

2.89

1.5

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.10

2.88

1.1

1.0

—

(3013512) EKG study

1466

13591

1.11

2.87

5.2

4.4

—

(3037121) Protein [Mass/volume] in Urine

205

1620

1.28

2.85

2.9

3.0

g/l

0.4

0.3

0.97

103

676

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

360

1.59

2.83

1.9

u/l

5999.7

1857.7

0.39

134

(3047189) Immunofixation for 24 hour Urine

261

1.69

2.79

1.8

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.27

2.76

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

300

1.64

2.76

3.0

2.5

—

(40768441) Liver Pathology biopsy report

262

1.69

2.75

1.5

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

2.86

2.74

1.2

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

5.01

2.72

1.3

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

6.01

2.69

1.3

1.0

—

(3001729) Color of Synovial fluid

2.66

2.62

2.7

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

680

1.40

2.61

1.5

1.4

iu/l

31.2

30.6

0.07

576

(3017446) Testosterone [Moles/volume] in Serum or Plasma

369

3138

1.19

2.59

2.7

2.1

nmol/l

12.5

12.0

0.66

317

2694

(3004716) Salmonella sp identified in Stool by Organism specific culture

190

1508

1.27

2.59

1.4

1.3

—

(3019150) Specific gravity of Urine by Refractometry

1001

9137

1.12

2.58

5.4

4.4

kg/l

1.0

0.34

177

1441

(3009214) Lutropin [Units/volume] in Serum or Plasma

682

1.40

2.57

1.4

u/l

10.4

10.7

0.09

550

(3016135) IgD [Mass/volume] in Serum

7.15

2.55

1.4

1.3

mg/l

242.2

121.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

395

1.53

2.53

1.5

1.6

u/ml

14.2

25.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

157

1.85

2.51

1.1

1.2

g/l

32.3

40.4

1.96

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.38

2.47

1.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.38

2.47

1.3

1.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.94

2.41

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.34

2.39

1.6

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

3.34

2.39

1.3

1.1

—

(3041184) Isoniazid [Presence] in Urine

6.25

2.37

2.6

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

6.25

2.37

2.4

4.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.12

2.36

8.0

9.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

501

1.44

2.34

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

995

0.70

2.34

1.7

—

(3008295) Osmolality of Serum or Plasma

454

1.46

2.28

1.4

1.3

mosm/kgh2o

273.2

277.8

0.79

338

(3004775) Volume in Urine collected for unspecified duration

405

1.49

2.28

2.4

2.2

564.5

651.4

1.11

246

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

169

1346

1.26

2.28

1.6

—

(40758292) HTLV I+II Ab panel - Serum

2.46

2.27

1.2

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

236

1951

1.22

2.27

1.2

iu/ml

120.5

143.4

0.41

678

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.24

2.17

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.56

2.09

1.0

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.26

2.07

1.2

1.3

u/l

18.9

19.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.50

2.05

1.0

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.50

2.05

2.3

5.7

—

(3000330) Specific gravity of Urine by Test strip

207

2493

0.82

2.04

4.8

3.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.00

1.2

mg/l

0.9

109.8

0.80

(3032773) Endomysium IgG Ab [Titer] in Serum

272

1.55

1.97

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

149

1.75

1.94

3.2

1.6

umol/l

92.9

136.4

0.79

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.05

1.90

1.3

1.2

u/l

23.2

473.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

196

1.64

1.89

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.65

1.86

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

375

1.44

1.84

1.3

1.4

—

(3048879) Bone marrow aspiration report

152

1.71

1.83

2.1

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

115

1.83

1.82

1.3

g/l

0.4

0.3

1.07

(3020191) Ethanol [Moles/volume] in Serum or Plasma

286

1.51

1.81

1.2

1.3

promille

1.2

1.1

0.09

217

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

254

1.54

1.81

1.6

1.7

u/field

1.6

2.3

0.39

175

(3028679) Herpes simplex virus Ab [Presence] in Serum

138

1.74

1.79

1.0

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.34

1.77

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

185

1.63

1.75

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

592

1.34

1.74

1.6

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

265

1.51

1.73

2.5

2.7

umol/l

23.4

34.5

—

(3035933) Granulocytes/100 leukocytes in Blood

2.00

1.69

2.5

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

1.68

0.0

6.1

—

8.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

262

2257

1.17

1.67

1.3

au/ml

47.5

58.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

260

1.50

1.65

2.0

1.8

—

(3019174) dRVVT (LA screen)

2.80

1.65

1.4

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.98

1.64

5.3

8.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

221

1.54

1.61

1.4

1.3

nmol/l

1.3

1.2

0.40

163

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.59

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

287

2503

1.16

1.58

2.4

au/ml

53.7

24.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

175

1.60

1.57

3.1

2.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

1.52

0.0

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.59

1.51

1.1

—

(3003338) MCHC [Mass/volume]

3293

32152

1.07

1.49

40.9

22.2

g/l

329.3

331.8

44.81

3274

31838

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

635

1.30

1.48

2.9

2.1

mg/l

25.9

27.1

0.07

144

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

101

1.78

1.48

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.13

1.44

1.6

7.3

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.13

1.44

1.2

1.9

mmol/l

4.2

4.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1446

15172

0.93

1.41

4.2

4.7

22.1

0.02

649

8033

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

213

1.51

1.40

1.7

1.5

g/l

1.0

0.9

0.31

213

(3008898) HLA-B27 [Presence]

110

891

1.24

1.40

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.25

1.40

1.2

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.42

1.39

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

724

0.74

1.38

1.7

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

381

1.37

1.38

1.0

1.1

u/ml

18.3

2.6

0.78

123

(1761482) Bacteria [#/volume] in Urine by Culture

113

1380

0.81

1.37

5.4

4.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.20

1.37

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

204

1757

1.17

1.36

3.1

3.3

u/ml

191.8

3125.2

1.14

166

1504

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.87

1.34

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.13

1.33

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.74

1.30

1.4

1.1

pmol/l

305.0

271.7

—

(3002256) Pathology report gross observation

617

5700

1.09

1.30

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

756

1.25

1.29

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

114

1.67

1.28

2.1

2.3

—

(4034850)

159

1351

1.18

1.27

12.5

11.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.22

1.24

1.0

1.3

mmol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

163

1.54

1.22

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

196

1.48

1.21

1.4

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.50

1.15

1.0

—

(1002224) Polysomnography panel

132

1116

1.19

1.14

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.69

1.13

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.85

1.13

11.0

13.0

mmol/l

5.7

5.4

0.27

(3035637) Corticotropin [Mass/volume] in Plasma

510

1.28

1.13

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.90

1.12

2.0

1.4

umol/l

35.7

44.1

0.67

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

217

1.43

1.11

1.2

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

674

1.24

1.09

1.4

1.7

mu/l

321.0

297.2

0.30

622

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

185

1.46

1.08

1.3

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

327

0.67

1.07

2.0

1.6

—

(3025130) Human papilloma virus identified in Specimen

244

1.40

1.07

1.9

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

338

0.68

1.06

1.0

ng/l

313.9

332.7

0.11

217

(3045414) Leukocytes [Presence] in Urine

218

1930

1.14

1.05

2.4

2.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.06

1.02

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

177

0.56

1.01

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

177

0.56

1.01

1.4

—

(3020650) Glucose [Presence] in Urine

1.65

1.00

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

176

0.57

0.99

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

176

0.57

0.99

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

594

0.77

0.97

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.97

0.0

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3982

39311

1.06

0.96

5.3

5.1

mmol/l

6.1

0.40

3592

35107

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

116

1.55

0.96

1.1

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

505

1.25

0.95

1.6

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

236

2626

0.89

0.94

1.2

—

(3014891) Appearance of Pleural fluid

1.65

0.94

1.7

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

150

1.47

0.92

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

339

0.71

0.92

1.0

ng/l

35.4

46.5

0.50

215

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.73

0.92

1.8

2.5

u/field

0.2

0.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.82

0.92

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

338

0.71

0.91

1.0

ng/l

793.7

668.9

1.04

211

(40768800) Prostate Pathology biopsy report

109

1272

0.85

0.89

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.65

0.88

1.2

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

289

1.32

0.87

3.5

5.1

u/ml

99.3

51.4

—

(40765096) Chromosome analysis panel by Banding

153

1.44

0.85

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3788

37395

1.05

0.83

4.4

4.2

mmol/l

1.3

7.73

3360

33329

(3011288) Drugs identified in Urine by Screen method

308

0.71

0.82

14.6

2.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

201

1806

1.12

0.81

1.4

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

621

0.80

0.81

2.1

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

106

1.51

0.78

1.9

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

149

0.60

0.78

1.3

1.5

—

(4027681)

173

1.39

0.78

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

251

1.32

0.78

1.8

1.5

nmol/l

0.2

0.3

1.53

189

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

157

1.40

0.76

1.5

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.76

0.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.70

0.75

2.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.84

0.73

1.0

1.9

—

(3012898) Urea [Moles/volume] in Urine

1.84

0.73

1.0

1.2

mmol/l

220.4

149.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.00

0.72

1.0

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

272

1.29

0.72

2.2

2.1

ug/min

61.2

207.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.67

0.72

2.2

—

(4281824)

400

0.77

0.71

1.0

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.92

0.70

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.92

0.70

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

182

0.66

0.70

1.3

1.5

—

(3005033) Fetal Nuchal fold Thickness US

143

0.63

0.69

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

144

0.62

0.69

1.2

1.4

—

(4198724)

1.56

0.68

1.2

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.60

0.68

2.5

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.60

0.68

2.1

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

556

1.19

0.68

1.6

1.3

nmol/l

13.8

0.7

0.49

529

(3024869) Neuronal Ab [Presence] in Serum

0.54

0.66

1.0

1.1

—

(3022621) pH of Urine by Test strip

316

2942

1.08

0.65

4.1

3.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

560

1.18

0.64

1.6

1.3

nmol/l

0.1

0.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.72

0.64

2.4

3.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

681

1.16

0.63

3.6

2.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.50

0.63

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

121

1.41

0.62

1.2

—

(1761868) Lipid panel - Serum or Plasma

1132

11692

0.96

0.61

3.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.46

0.61

1.8

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

137

0.66

0.60

1.7

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

244

0.74

0.60

2.0

1.8

—

(3035285) Chloride [Moles/volume] in Venous blood

695

1.15

0.59

3.6

2.4

mmol/l

105.4

105.6

0.09

686

(3041354) Potassium [Moles/volume] in Venous blood

695

1.15

0.59

3.6

2.4

mmol/l

4.1

0.11

686

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.59

0.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

131

1.38

0.59

1.7

1.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

197

0.71

0.58

1.3

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.51

0.58

1.3

1.9

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.72

0.57

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.67

0.56

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

495

0.83

0.56

1.7

1.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

213

1.27

0.53

3.9

6.3

—

(3032057) Clostridioides difficile [Presence] in Stool

125

1.36

0.53

2.1

1.9

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

666

1.14

0.52

2.0

1.9

pmol/l

207.9

202.6

0.19

618

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

847

1.12

0.51

1.1

1.2

mmol/l

3.8

3.9

0.33

782

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

538

1.15

0.49

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

382

1.18

0.47

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

557

0.86

0.45

3.4

4.5

umol/l

320.8

345.4

0.48

473

(40761535) Cells panel - Urine sediment

412

3931

1.05

0.44

4.5

3.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.37

0.44

1.1

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

106

962

1.10

0.44

1.2

1.3

mg/l

774.4

549.8

0.41

898

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

1.33

0.42

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1016

0.90

0.41

7.0

3.8

mg/l

27.7

29.9

0.29

651

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.1

—

7.8

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.40

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

492

1.14

0.40

1.6

1.3

nmol/l

—

(3020874) Milk IgE Ab [Units/volume] in Serum

123

1.30

0.40

1.0

1.1

u/ml

0.8

2.3

—

(3025315) Body weight

1.47

0.40

3.4

4.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

265.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

164

1528

1.08

0.39

1.5

1.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

103

0.68

0.39

1.1

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

205

1.22

0.39

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

106

1.32

0.39

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1049

10746

0.97

0.39

2.9

3.3

ug/l

0.7

0.8

2.62

752

7703

(3049717) Cytology report of Urine Cyto stain

236

2229

1.06

0.38

3.0

2.9

—

(3000285) Sodium [Moles/volume] in Blood

1.30

0.37

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

143

1.26

0.36

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

216

1.20

0.36

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

109

1004

1.09

0.36

2.0

1.7

mg/l

29.4

3.4

6.54

719

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

488

1.13

0.36

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.43

0.35

1.8

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

112

1034

1.09

0.35

2.8

3.2

u/ml

91.0

711.0

1.56

103

946

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.40

0.35

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.36

0.34

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.36

0.34

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

424

1.13

0.34

1.7

2.0

u/field

1.8

1.7

0.02

151

(3005570) Glucose [Moles/volume] in Urine

443

1.13

0.34

2.5

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

748

1.10

0.34

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.30

0.33

1.8

1.3

—

640.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.30

0.33

14.7

11.4

—

(4133840)

0.67

0.32

1.0

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3927

39039

1.03

0.32

4.9

4.7

mmol/l

4.4

4.5

4.48

3529

35425

(4211845)

238

1.18

0.32

4.9

3.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.28

0.32

1.0

—

(40768793) Breast Pathology biopsy report

770

1.09

0.32

1.5

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4028

40059

1.03

0.32

5.4

5.3

mmol/l

2.5

2.6

7.90

3622

36144

(3006462) Nitrate [Presence] in Urine

220

1.18

0.31

5.1

4.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

248

1.17

0.31

2.3

2.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

428

1.12

0.30

1.2

mmol/l

7.2

7.7

0.48

306

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

581

1.10

0.30

1.1

iu/ml

77.9

72.2

0.03

110

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

103

1.26

0.28

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3887

38671

1.02

0.26

4.8

4.7

mmol/l

1.4

3.40

3465

34800

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

357

1.12

0.26

1.1

—

27.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

141

1.21

0.26

1.1

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

114

1.23

0.25

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

133

1.20

0.24

1.7

1.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

513

1.09

0.24

1.2

1.3

pmol/l

289.3

269.0

0.14

385

(3023487) Leukocytes [#/volume] in Peritoneal fluid

169

0.83

0.23

1.8

2.1

e6/l

393.7

5203.6

—

121

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

1.22

0.23

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

106

1.23

0.23

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.28

0.23

1.0

1.2

u/l

8.8

12.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.28

0.23

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.25

0.22

2.2

2.0

umol/l

15.6

18.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

135

1.19

0.21

18.1

11.7

nmol/l

863.6

815.3

0.15

126

(3014271) Vancomycin [Susceptibility]

315

1.11

0.21

2.9

3.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

2.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

126

1.19

0.21

1.1

1.5

pmol/l

18.0

15.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

230

0.87

0.21

1.6

1.4

pmol/l

60.2

178.0

—

(3014051) Protein [Presence] in Urine by Test strip

1026

0.94

0.20

3.1

2.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

202

1.14

0.20

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.22

0.20

1.3

2.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.21

0.19

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

212

1.13

0.19

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.19

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

812

1.06

0.19

2.0

1.5

nmol/l

1.1

0.8

1.83

670

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

175

1.14

0.18

1.1

u/l

1.0

1.2

1.15

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

121

0.83

0.18

1.6

—

(3023410) Appearance of Cerebral spinal fluid

361

1.08

0.15

1.3

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

667

0.94

0.15

1.7

1.5

pmol/l

173.8

240.4

0.60

649

(3006653) Thiamine [Moles/volume] in Blood

202

0.89

0.14

1.0

1.2

nmol/l

135.4

139.9

0.11

202

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

156

1611

0.97

0.14

2.8

3.9

u/ml

62.9

76.0

0.28

151

1547

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

160

1.13

0.14

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

159

0.88

0.13

1.1

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

106

0.85

0.13

1.1

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

0.83

0.13

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

326

1.07

0.12

1.6

2.0

ug/l

1.7

2.1

0.54

273

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

114

1.14

0.11

2.1

2.3

mmol/l

8.0

7.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

833

0.96

0.11

1.6

1.7

iu/l

5.2

5.0

0.05

256

(3019225) pH of Specimen

490

4833

1.02

0.11

5.5

4.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

381

3871

0.98

0.11

1.4

—

(4094501)

107

1105

0.97

0.10

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.04

0.09

2.2

1.1

umol/24h

1.9

1.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.11

0.09

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.05

0.08

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

312

1.06

0.08

1.1

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

224

1.07

0.08

2.6

2.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.78

0.08

2.8

2.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

140

1369

1.02

0.08

1.6

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.77

0.08

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

440

1.05

0.08

2.3

3.3

mg/l

66.4

37.0

0.51

343

(3051593) INR in Capillary blood by Coagulation assay

287

0.94

0.08

6.5

13.2

—

(4024509)

480

0.96

0.08

1.7

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

826

1.03

0.07

1.2

1.4

e6/l

98.2

1022.0

3.32

673

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.03

0.07

1.3

—

(3002619) Bacteria identified in Specimen by Culture

0.86

0.07

1.6

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

182

0.93

0.05

1.2

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1888

18934

1.00

0.05

4.8

5.5

ug/l

3.6

3.9

0.13

1649

16804

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

171

0.94

0.05

2.1

2.3

umol/l

68.0

54.0

—

133

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

164

1619

1.01

0.04

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

945

1.02

0.03

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

826

1.02

0.03

1.2

1.4

e6/l

20.3

22.9

0.07

641

(1617658) Protocol used for examination of sentinel lymph nodes

270

0.96

0.03

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.09

0.03

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

360

0.97

0.03

2.3

1.9

—

(3027944) Amphetamines [Presence] in Urine

460

1.02

0.02

2.0

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

123

1219

1.01

0.02

2.7

2.3

ug/min

138.1

95.0

0.60

708

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.06

0.01

1.4

1.2

umol/24h

0.8

0.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

116

0.95

0.00

2.1

2.0

ug/l

1.2

1.5

0.16

108

(3000764) Benzodiazepines [Presence] in Urine

466

0.99

0.00

2.0

1.9

—

(3011985) Renin [Units/volume] in Plasma

556

0.99

0.00

1.3

1.4

mu/l

50.2

62.8

0.32

483

(4146454)

574

1.01

0.00

2.3

2.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

198

1.01

0.00

1.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

115

1.04

0.00

1.0

1.1

u/ml

0.6

3.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

195

0.97

0.00

1.4

1.2

mmol/l

6.1

6.2

0.08

184

(3027008) Opiates [Presence] in Urine

468

1.00

0.00

2.0

1.9

—

(3006270) Folate [Moles/volume] in Blood

415

1.01

0.00

1.2

nmol/l

267.5

335.4

1.49

330

(3022689) Creatine [Moles/volume] in Urine

114

0.96

0.00

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

266

1.02

0.00

1.1

1.2

mmol/l

14.4

11.6

0.73

(44806420)

177

1.02

0.00

2.1

2.4

—

(3016879) Cocaine [Presence] in Urine

433

0.99

0.00

2.1

1.9

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.98

0.00

1.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

3776.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.92

0.00

1.5

ng/l

183.9

148.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.97

0.00

1.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

6.6

—

49.7

—

(4212803)

0.98

0.00

1.2

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.94

0.00

2.0

3.5

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1614.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.02

0.00

1.0

1.2

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033799) Differential panel - Peritoneal fluid

150

1.00

0.00

2.1

1.9

—

(4038314)

0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3028300) Cannabinoids [Presence] in Urine

470

1.00

0.00

1.9

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

7.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_HOSPITAL_MAIN – ILD, hospital admissions 1, main diag only

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

ILD, hospital admissions 1, main diag only

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for ILD, hospital admissions 1, main diag only (ILD_HOSPITAL_MAIN)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints